The Holistic Prevention, Management and Treatment of PCOs analysed through Conventional Medicine Research and Studies(references page of 1 - 699)

"The Holistic Prevention, Management and Treatment of PCOs analysed through Conventional Medicine Research and Studies" provides you the accurate information of the use of natural sources to prevent, management and treatment of Polycystic Ovarian Syndrome, because all presentations are proven through convention research and studies found in PubMed. This is the second time, a research paper has been written this way to general public that you will not find any where in the net. We would like to provide more of this kind the research, but unfortunately, it is time consuming and burdened financially, we have run out of time and the site will be shut down Monday(July 6, 2015). If you like what you read, please donate generously to our site.
at http://kylejnorton.blogspot.ca/
Kyle J. Norton

The references page of 1 - 699

References

(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)

(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)

(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O¹.(PubMed)

(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF¹, Li XL, Fang F, Du MR.(PubMed)

(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)

(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R¹, Kedzia A, Okopień B.(PubMed)

(7) The clinical evaluation of hirsutism by Somani N¹, Harrison S, Bergfeld WF.(PubMed)

(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB¹, Evans WS, Nestler JE.(PubMed)

(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA¹, Arduc A², Tuna MM¹, Karakılıc E¹, Dagdelen I¹, Tutuncu Y¹, Berker D¹, Guler S¹.(PubMed)

(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO¹.(PubMed)

(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO¹, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)

(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J¹, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)

(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK¹, Katalenich B², Nagireddy P³, Chabbra P⁴, Kuhadiya N⁵, Fonseca V¹.(PubMed)

(14) Acne in hirsute women by Lumezi BG¹, Pupovci HL¹, Berisha VL¹, Goçi AU², Gerqari A³.(PubMed)

(15) Obesity and polycystic ovary syndrome by Naderpoor N¹, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)

(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic  manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)

(17) Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. by Whigham LD¹, Butz DE², Dashti H³, Tonelli M³, Johnson LK¹, Cook ME², Porter WP⁴, Eghbalnia HR⁵, Markley JL⁶, Lindheim SR⁷, Schoeller DA⁸, Abbott DH⁹, Assadi-Porter FM¹⁰.(PubMed)

(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA¹, Azizia MM¹, Hardiman PJ².(PubMed)

(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M¹, Kjaer SK², Jensen A¹, Munk C¹, Mellemkjaer L³.(PubMed)

(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E¹.(PubMed)

(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E¹, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)

(22) Health-related quality of life and its relationship with clinical symptoms among Iranian patients with polycystic ovarian syndrome by Bazarganipour F1, Ziaei S1, Montazeri A2, Foroozanfard F3, Faghihzadeh S4(PubMed)

(23) Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: A randomized control trial by Nidhi R1, Padmalatha V, Nagarathna R, Amritanshu R.(PubMed)

(24) The relationship between clinicobiochemical markers and depression in women with polycystic ovary syndrome by Rahiminejad ME1, Moaddab A2, Rabiee S3, Esna-Ashari F4, Borzouei S5, Hosseini SM1.(PubMed)

(25) Autonomic dysfunction in women with polycystic ovary syndrome by Hashim ZH1, Hamdan FB1, Al-Salihi AR2.(PubMed)

(26) Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup? by Rachmiel M1, Kives S, Atenafu E, Hamilton J.(PubMed)

(27) [Polycystic ovarian syndrome and obstructive sleep apnea]. [Article in Bulgarian] Gateva A, Kamenov Z, Mondeshki Ts, Bilyukov R, Georgiev O.(PubMed)

(28) A case report demonstrating the efficacy of a comprehensive cognitive-behavioral therapy approach for treating anxiety, depression, and problematic eating in polycystic ovarian syndrome by Correa JB1, Sperry SL, Darkes J.(PubMed)

(29) Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS) by Lenarcik A1, Bidzińska-Speichert B, Tworowska-Bardzińska U, Krępuła K.(PubMed)

(30) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families by Govind A1, Obhrai MS, Clayton RN.(PubMed)

(31) Lifestyle changes in women with polycystic ovary syndrome. Moran LJ1, Hutchison SK, Norman RJ, Teede HJ.(PubMed)

(32) Environmental risk factors for women with polycystic ovary syndrome in china: a population-based case-control study by Zhang J1, Liu XF1, Liu Y1, Xu LZ1, Zhou LL1, Tang LL1, Zhuang J1, Li TT1, Guo WQ2, Hu R3, Qiu DS3, Han DW3.(PubMed)

(33) [Analysis of environmental factors and polycystic ovary syndrome]. [Article in Chinese] by Huang WJ1, Liu JY, Li LN.(PubMed)

(34) Phenotypes and enviromental factors: their influence in PCOS by Diamanti-Kandarakis E1, Christakou C, Marinakis E.(PubMed)

(35) Industrial endocrine disruptors and polycystic ovary syndrome by Palioura E1, Diamanti-Kandarakis E.(PubMed)

(36) Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS) by Rutkowska A1, Rachoń D.(PubMed)

(37) PCOS in adolescence and type 2 diabetes by Carreau AM1, Baillargeon JP.(PubMed)

(38) [Adverse events of psychotropic drugs]. [Article in Japanese] by Watanabe K, Kikuchi T.(PubMed)

(39) [Characteristics of women with epilepsy who developed polycystic ovary syndrome owing to the therapy with valproate sodium]. [Article in Japanese] Minagawa K1, Watanabe T, Oyanagi R.(PubMed)

(40) A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy by Hu X1, Wang J, Dong W, Fang Q, Hu L, Liu C.(PubMed)

(41) Study on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome by Meczekalski B1, Nawrot R, Nowak W, Czyzyk A, Kedzia H, Gozdzicka-Jozefiak A.(PubMed)

(42) Association study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome by  Wang X1, Yang Y1, Huang Y2, Wang Q3.(PubMed)

(43) [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome]. [Article in Chinese] by Chen ZJ1, Shi YH, Zhao YR, Li Y, Tang R, Zhao LX, Chang ZH.(PubMed)

(44) [Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients]. [Article in Chinese] by Diao XH1, Shi YH, Gao Q, Wang LC, Tang R, Chen ZJ.(PubMed)

(45) Association between vaspin rs2236242 gene polymorphism and polycystic ovary syndrome risk by Kohan L1, Zarei A2, Fallahi S3, Tabiee O4.(PubMed)

(46) Female Obesity and Infertility by Talmor A¹, Dunphy B².(PubMed)

(47) [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].[Article in Bulgarian] by Komsa-Penkova R, Golemanov G, Georgieva G, Slavov N, Popovski K, Ivanov P, Kovacheva K, Atanasova M, Blajev A.(PubMed)

(48) Endothelial function in young women with polycystic ovary syndrome (PCOS): Implications of body mass index (BMI) and insulin resistance by El-Kannishy G¹, Kamal S², Mousa A², Saleh O², Badrawy AE², Farahaty RE², Shokeir T².(PubMed)

(49) Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With Clinical Symptoms Among Women With Polycystic Ovary Syndrome by Esmaeilzadeh S, Andarieh MG¹, Ghadimi R, Delavar MA.(PubMed)

(50) Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India by Sinha U¹, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK.(PubMed)

(51) The evaluation and management of hirsutism by Azziz R¹.(PubMed)

(52) Pcos.[No authors listed](PubMed)

(53) DHEA, DHEAS and PCOS by Goodarzi MO¹, Carmina E², Azziz R³.(PubMed)

(54) Adrenal androgen excess and body mass index in polycystic ovary syndrome by Moran C¹, Arriaga M, Arechavaleta-Velasco F, Moran S.(PubMed)

(55) Superactive human leptin antagonist reverses leptin-induced excessive progesterone and testosterone secretion in porcine ovarian follicles by blocking leptin receptors by Gregoraszczuk EL¹, Rak A.(PubMed)

(56) Reproduction in hens: is testosterone necessary for the ovulatory process? by Rangel PL¹, Gutierrez CG².(PubMed)

(57) The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS) by Wassell J¹, Michail M, Soliman N, Wardle PG.(PubMed)

(58) Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance by Nawrocka J¹, Starczewski A.(PubMed)

(59) Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome by Chun S¹.(PubMed)

(60) [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].[Article in Chinese] by Li Y¹, Wei LN, Xiong YL, Liang XY.(PubMed)

(61) Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India by Sinha U¹, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK.(PubMed)

(62) Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism by Pei YJ¹, Wang AM, Zhao Y, Yan L, Li M, White RE, Han GC.(PubMed)

(63) Polycystic ovary syndrome and chronic autoimmune thyroiditis by Novais Jde S¹, Benetti-Pinto CL, Garmes HM, Jales RM, Juliato CR.(PubMed)

(64) Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS by Dittrich R¹, Kajaia N, Cupisti S, Hoffmann I, Beckmann MW, Mueller A.(PubMed)

(65) [Association between levels of serum leptin and insulin resistance in patients with polycystic ovary syndrome].[Article in Chinese]by Cheng X¹, Guo J², Xie J³.(PubMed)

(66) [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].[Article in Chinese]by Liu ZA¹, Xue YM, Chen LX, Cai Q, Chen H, Zhang J, Cui QH, Ge J, Yuan T.(PubMed)

(67) Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome by Al-Zubeidi H, Klein KO.(PubMed)

(68) Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome by Allen HF¹, Mazzoni C, Heptulla RA, Murray MA, Miller N, Koenigs L, Reiter EO.(PubMed) 

(69) [Polycystic ovary syndrome: physiopathology review].[Article in Spanish]by Fux Otta C, Fiol de Cuneo M, Szafryk de Mereshian P.(PubMed)

(70) Trp28Arg/Ile35Thr LHB gene variants are associated with elevated testosterone levels in women with polycystic ovary syndrome by Batista MC¹, Duarte Ede F², Borba MD³, Zingler E⁴, Mangussi-Gomes J³, dos Santos BT⁵, de Moraes OL⁵, Hayashida SA⁶, Baracat EC⁶, da Rocha Neves Fde A⁵, Maciel GA⁶, Bachega TA⁷, Barra GB⁸, Lofrano-Porto A⁹.(PubMed)

(71) Polycystic ovary syndrome woman with heterozygous androgen receptor gene mutation who gave birth to a child with androgen insensitivity syndrome by Nam H¹, Kim CH², Cha MY¹, Kim JM³, Kang BM¹, Yoo HW³.(PubMed)

(72) The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS by Baculescu N¹.(PubMed)

(73) Study on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome by Meczekalski B¹, Nawrot R, Nowak W, Czyzyk A, Kedzia H, Gozdzicka-Jozefiak A.(PubMed)

(74) Association study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome by Wang X¹, Yang Y¹, Huang Y², Wang Q³.(PubMed)

(75) Epigenetics and migraine; complex mitochondrial interactions contributing to disease susceptibility by Roos-Araujo D¹, Stuart S¹, Lea RA¹, Haupt LM¹, Griffiths LR².(PubMed)

(76) Mechanisms linking obesity to insulin resistance and type 2 diabetes by Kahn SE¹, Hull RL, Utzschneider KM.(PubMed)

(77) The effect of past antibiotic exposure on diabetes risk by Boursi B¹, Mamtani R², Haynes K³, Yang YX⁴.(PubMed)

(78) Portal versus systemic venous drainage of the pancreatic graft: the effect on glucose metabolism in pancreas and kidney transplant recipients by Havrdova T¹, Boucek P², Jedinakova T², Lipar K³, Kocik M³, Skibova J⁴, Saudek F².(PubMed)

(79) The mechanisms linking adiposopathy to type 2 diabetes by Yang J¹, Kang J, Guan Y.(PubMed)

(80) Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells by Bhattacharya S¹, Oksbjerg N, Young JF, Jeppesen PB.(PubMed)

(81) Insulin resistance and adipogenesis: role of transcription and secreted factors by Penkov DN¹, Egorov AD, Mozgovaya MN, Tkachuk VA.(PubMed)

(82) Insulin resistance in PCOS by Diamanti-Kandarakis E¹(PubMed)

(83) Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function? by van Houten EL¹, Visser JA².(PubMed)

(84)Epidemiologic investigation of polycystic ovarian syndrome (PCOS) in Han ethnic women of reproductive age in Liaoning Province, China by Jiao J, Fang Y, Wang T, Wang Z, Zhou M, Wang X.(PubMed)

(85) Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?by Muscogiuri G¹, Policola C, Prioletta A, Sorice G, Mezza T, Lassandro A, Della Casa S, Pontecorvi A, Giaccari A.(PubMed)

(86) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome by Wehr E¹, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, Obermayer-Pietsch B.(PubMed)

(87) The association of androgenetic alopecia and insulin resistance is independent of hyperandrogenemia: A case-control study by Kartal D1, Borlu M, Çınar SL, Ferahbaş A, Ulaş Y, Ünlühızarcı K, Ukşal Ü, Keleştimur F.(PubMed)

(88) GG genotype Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome by Jędrzejuk D1, Laczmański L, Kuliczkowska J, Lenarcik A, Trzmiel-Bira A, Hirnle L, Dorobisz U, Milewicz A, Lwow F, Urbanovych A, Słoka N.(PubMed)

(89) Women self-perception of excess hair growth, as a predictor of clinical hirsutism: a population-based study by Kazemi H1, Ramezani Tehrani F, Minooee S, Khalili D, Azizi F.(PubMed)

(90) Evaluation of only the chin or lower abdomen for predicting hirsutism by Rashidi H1, Parizi ZT, Mohammadi M.(PubMed)

(91) The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS) by Mick Rae, Cathal Grace, Kirsten Hogg, Lisa Marie Wilson, Sophie L. McHaffie,2 Seshadri Ramaswamy, Janis MacCallum, Fiona Connolly, Alan S. McNeilly,and Colin Duncan (PubMed)

(92) Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary by Hogg K1, McNeilly AS, Duncan WC.(PubMed)

(93) Endocrine-Disrupting Chemicals: Some Actions of POPs on Female Reproduction by Ewa L. Gregoraszczuk* and Anna Ptak(PubMed)

(94) Food Adulteration and Consumer Awareness in Dhaka City, 1995-2011 By Sharifa Nasreencorresponding author1 and Tahmeed Ahmed(PubMed)

(95) FAO/WHO. Assuring food safety and quality: guidelines for strengthening national food control systems. Rome: Food and Agriculture Organization; 2003. p. 28. (FAO food and nutrition paper no. 76).

(96) Park K. Park's textbook of preventive and social medicine. 18th ed. Jabalpur: Banarsidas Bhanot; 2005. p. 481.

(97) Menstrual effects among women exposed to polychlorinated biphenyls and dibenzofurans by Yang CY1, Huang TS, Lin KC, Kuo P, Tsai PC, Guo YL.(PubMed)

(98) Endocrine modulators in the food chain and environment by Nilsson R¹.(PubMed)

(99) Adipose tissue dysfunction, adipokines and low-grade chronic inflammation in PCOS by Spritzer PM¹, Lecke SB², Satler F³, Morsch DM⁴.(PubMed)

(100) Adipose tissue dysfunction in polycystic ovary syndrome by Villa J¹, Pratley RE.(PubMed)

(101) Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment by Garruti G¹, Depalo R, Vita MG, Lorusso F, Giampetruzzi F, Damato AB, Giorgino F.(PubMed)

(102) Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates by Tsilchorozidou T¹, Honour JW, Conway GS.(PubMed)

(103) Increased testosterone levels and cortisol awakening responses in patients with borderline personality disorder: Gender and trait aggressiveness matter by Rausch J¹, Gäbel A¹, Nagy K¹, Kleindienst N², Herpertz SC¹, Bertsch K³.(PubMed|)

(104) Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability? by Steen NE¹, Methlie P, Lorentzen S, Hope S, Barrett EA, Larsson S, Mork E, Almås B, Løvås K, Agartz I, Melle I, Berg JP, Andreassen OA.(PubMed)

(105) Elevated maternal cortisol leads to relative maternal hyperglycemia and increased stillbirth in ovine pregnancy by Keller-Wood M¹, Feng X², Wood CE³, Richards E², Anthony RV⁴, Dahl GE⁵, Tao S⁵.(PubMed)

(106) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man by Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC.(PubMed)

(107) Glucose Homeostasis and Starvation(Glucose Homeostasis)

(108) A case report of adult lead toxicity following use of Ayurvedic herbal medication by Breeher L¹, Gerr F, Fuortes L.(PubMed)

(109) Diseases and ConditionsFemale infertility(Mayo clinic)
(110) Chronic alcohol administration increases serum prolactin level and pituitary cell proliferation, and alters hypothalamus neurotransmitters in rat by Li N¹, Shi X, Fu S, Zhu F, Yang S.(PubMed)
(111) Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas by Ono M¹, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T.(PubMed)
(112) [Hormonal disorders, menstrual irregularities and future fertility].[Article in German] by Tscherne G¹.(PubMed)
(113) Influence of hyperprolactinaemia due to metoclopramide on gonadal function in men by Falaschi P, Frajese G, Sciarra F, Rocco A, Conti C.(PubMed)
(114) Growth hormone, prolactin, and sexuality by Galdiero M¹, Pivonello R, Grasso LF, Cozzolino A, Colao A.(PubMed)
(115) Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation by Hickey M¹, Higham JM, Fraser I.(PubMed)
(116) Excessive uterine bleeding by Talib HJ¹, Coupey SM.(PubMed)
(117)  [The use of the preparation Anteovin in dysfunctional uterine hemorrhages and PCOS].[Article in Bulgarian] by Kolarov G, Nalbanski B, Orbetsova M, Kamenov Z, Sirakov M, Filipov E.(PubMed)
(118) Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives by Mastorakos G¹, Koliopoulos C, Creatsas G.(PubMed)
(119) Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model by Di Pietro M¹, Parborell F, Irusta G, Pascuali N, Bas D, Bianchi MS, Tesone M, Abramovich D.(PubMed)
(120) Molecular aspects of bovine cystic ovarian disease pathogenesis by Ortega HH¹, Marelli BE², Rey F³, Amweg AN⁴, Diaz PU⁵, Stangaferro ML⁶, Salvetti NR⁷.(PubMed)
(121) Relationship between ovarian cysts and infertility: what surgery and when? by Legendre G¹, Catala L², Morinière C², Lacoeuille C², Boussion F², Sentilhes L², Descamps P².(PubMed)
(122) Altered expression of transforming growth factor-beta isoforms in bovine cystic ovarian disease by Matiller V¹, Stangaferro ML, Díaz PU, Ortega HH, Rey F, Huber E, Salvetti NR.(PubMed)
(123) Angiogenesis in the ovary by Redmer DA¹, Reynolds LP.(PubMed)
(124) Ovarian and endometrial function during hormonal contraception by ESHRE Capri Workshop Group.(PubMed)
(125) Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues by Biljan MM¹, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL.(PubMed)
(126) Ovarian neoplasms, functional ovarian cysts, and oral contraceptives by Vessey M, Metcalfe A, Wells C, McPherson K, Westhoff C, Yeates D.(PubMed)
(127) Treating ovarian cysts with Chinese herbs: a case report by Qu F¹, Zhou J, Yu Y, Linc Q, Jiang YM.(PubMed)
(128) Treating adolescent ovarian cysts with Chinese herbs: a case report by Qu F¹, Zhou J, Huang H.(PubMed)
(129) A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome by Shen CC¹, Yang AC¹, Hung JH¹, Hu LY¹, Tsai SJ².(PubMed)
(130) Cancer risk and PCOS by Dumesic DA¹, Lobo RA.(PubMed)
(131) Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome by Kelley CE¹, Brown AJ¹, Diehl AM¹, Setji TL¹.(PubMed)
(132) Nonalcoholic fatty liver disease and polycystic ovary syndrome by Vassilatou E¹.(PubMed)
(133) An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome by Brzozowska MM¹, Ostapowicz G, Weltman MD.(PubMed)
(134) Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism by Bohdanowicz-Pawlak A¹, Lenarcik-Kabza A, Brona A, Kuliczkowska-Płaksej J, Łaczmański Ł, Zaleska-Dorobisz U, Milewicz A.(PubMed)
(135) Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity by Joham AE¹, Boyle JA², Zoungas S¹, Teede HJ³.(PubMed)
(136) Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors by Shi Y¹, Cui Y², Sun X³, Ma G⁴, Ma Z⁴, Gao Q⁴, Chen ZJ⁵.(PubMed)
(137) Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile by Barcellos CR¹, Lage SH, Rocha MP, Hayashida SA, Baracat EC, Romano A, Brito VN, Marcondes JA.(PubMed)
(138) Metabolic risk in PCOS: phenotype and adiposity impact by Moran LJ¹, Norman RJ², Teede HJ³.(PubMed)
(139)Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations by Housman E¹, Reynolds RV².(PubMed)
(140) Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies by Mendoza N¹, Simoncini T, Genazzani AD.(PubMed)
(141) Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study by Panidis D¹, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D.(PubMed)
(142) Thyroid disorders and polycystic ovary syndrome: An emerging relationship by Singla R¹, Gupta Y², Khemani M³, Aggarwal S⁴.(PubMed)
(143) Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship by Enzevaei A¹, Salehpour S¹, Tohidi M², Saharkhiz N¹.(PubMed)
(144) A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes by Gower BA¹, Goss AM².(PubMed)
(145) Polycystic ovarian syndrome and Cushing's syndrome: a persistent diagnostic quandary by Brzana J¹, Yedinak CG², Hameed N¹, Plesiu A¹, McCartney S², Fleseriu M³.(PubMed)
(146) How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? by Kaltsas GA¹, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB.(PubMed)
(147) Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome by Putignano P¹, Bertolini M, Losa M, Cavagnini F.(PubMed)
(148) Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome by Pall ME¹, Lao MC, Patel SS, Lee ML, Ghods DE, Chandler DW, Friedman TC.(PubMed)
(149) Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice by Wang X¹, Chen YG, Ma L, Li ZH, Li JY, Liu XG, Zou JL, Wu JH.(PubMed)
(150) [Profiles of irregular bleeding induced by low-dose hormone therapy and Chinese formulated herbs products].[Article in Chinese] by Wang SH¹, Lin SQ, Gui QF, Jin MJ, Jiang Y.(PubMed)
(151) [Observation on therapeutic effect of warming acupuncture and moxibustion combined with Chinese drugs on ovarian cysts].[Article in Chinese] by Li YM¹, Song LZ, Wang P, Jiang HJ.(PubMed)
(152) Inhibitory effects of Scutellaria barbata D. Don on human uterine leiomyomal smooth muscle cell proliferation through cell cycle analysis by Lee TK¹, Lee DK, Kim DI, Lee YC, Chang YC, Kim CH.(PubMed)
(153) Treatment of Nonalcoholic Fatty Liver Disease with Total Alkaloids in Rubus aleaefolius Poir through Regulation of Fat Metabolism by Li Y¹, Zhao J², Zheng H³, Zhong X², Zhou J³, Hong Z².(PubMed)
(154) Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs by Zhang Y¹, Si Y, Zhai L, Yang N, Yao S, Sang H, Zu D, Xu X, Qin S, Wang J.(PubMed)
(155) Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis by Shi KQ¹, Fan YC, Liu WY, Li LF, Chen YP, Zheng MH.(PubMed)
(156) Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America by Ranilla LG¹, Kwon YI, Apostolidis E, Shetty K.(PubMed)
(157) A diet formula of Puerariae radix, Lycium barbarum, Crataegus pinnatifida, and Polygonati rhizoma alleviates insulin resistance and hepatic steatosis in CD-1 mice and HepG2 cells by Liu J¹, Zhang H, Ji B, Cai S, Wang R, Zhou F, Yang J, Liu H.(PubMed)
(158) Obesity and Polycystic Ovary Syndrome by Susan Sam, MD(PubMed)
(159) The role of obesity in the development of polycystic ovary syndrome by Motta AB(PubMed)
(160) Polycystic ovary syndrome, obesity and reproductive implications by Hirschberg AL. (PubMed)
(161) [Effect of Pi transportation, dampness resolving and phlegm expelling herbs on the obesity degree, fat hormones, and leptin resistance in diet-induced obesity rats].[Article in Chinese] by Jiang P, Jiang YH.(PubMed)
(162) Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings by Arentz S, Abbott JA, Smith CA, Bensoussan A.(PubMed)
(163) Causes of amenorrhea in Korea: Experience of a single large center by Kwon SK¹, Chae HD¹, Lee KH¹, Kim SH¹, Kim CH¹, Kang BM¹.(PubMed)
(164) Amenorrhea: An Approach to Diagnosis and Management  DAVID A. KLEIN, MD, MPH, San Antonio Military Medical Center, San Antonio, Texas  MERRILY A. POTH, MD, Uniformed Services University of the Health Sciences, Bethesda, Maryland  Am Fam Physician. 2013 Jun 1;87(11):781-788.(The American physician)
(165) The role of serum testosterone in early pregnancy outcome: a comparison in women with and without polycystic ovary syndrome by Lathi RB¹, Dahan MH², Reynolds-May MF³, Milki AA¹, Behr B¹, Westphal LM¹.(PubMed)
(166) The polycystic ovary syndrome does not predict further miscarriage in Japanese couples experiencing recurrent miscarriages by Sugiura-Ogasawara M¹, Sato T, Suzumori N, Kitaori T, Kumagai K, Ozaki Y.(PubMed)
(167) Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women by Tulppala M¹, Stenman UH, Cacciatore B, Ylikorkala O.(PubMed)
(168)Dysregulation of ovarian follicular development in female rat: LH decreases FSH sensitivity during preantral-early antral transition by Orisaka M¹, Hattori K, Fukuda S, Mizutani T, Miyamoto K, Sato T, Tsang BK, Kotsuji F, Yoshida Y.(PubMed)
(169) The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques by Tarlatzis BC¹, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.(PubMed)
(170) Polycystic Ovarian Syndrome (Net doctor) 
(171) 54G/C polymorphism of SREBF-1 gene is associated with polycystic ovary syndrome by Li L¹, Yun JH¹, Ryoo JE², Lee KJ³, Choi BC⁴, Baek KH⁵.(PubMed)
(172) Association study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome by Wang X¹, Yang Y¹, Huang Y², Wang Q³.(PubMed)
(173) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(174) PCOS in adolescence and type 2 diabetes by Carreau AM¹, Baillargeon JP.(PubMed)
(175) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H¹, Deeks A, Moran L.(PubMed)
(176) New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach by Ravn P¹.(PubMed)
(177) Cardiometabolic aspects of the polycystic ovary syndrome by Randeva HS¹, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, Lehnert H.(PubMed)
(178) Systematic review of herbs and dietary supplements for glycemic control in diabetes by Yeh GY¹, Eisenberg DM, Kaptchuk TJ, Phillips RS.(PubMed)
(179) A systems biology approach to understanding the mechanisms of action of chinese herbs for treatment of cardiovascular disease by Li B¹, Xu X, Wang X, Yu H, Li X, Tao W, Wang Y, Yang L.(PubMed)
(180) Infertility(CDC) 
(181)  Why Do So Few Couples Seek Infertility Treatment? By Jacky Boivin, PhD. Fall 2007
(182) Fertility and the Aging Male by Isiah D Harris, MD,¹ Carolyn Fronczak,² Lauren Roth, MD,¹ and Randall B Meacham, MD(PubMed)
(183) Status of clomiphene citrate and metformin for infertility in PCOS by Misso ML¹, Teede HJ, Hart R, Wong J, Rombauts L, Melder AM, Norman RJ, Costello MF.(PubMed)
(184) Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial by Badawy A¹, Abdel Aal I, Abulatta M.(PubMed)
(185) Comparison of letrozole versus tamoxifen effects in clomiphen citrate resistant women with polycystic ovarian syndrome by El-Gharib MN¹, Mahfouz AE¹, Farahat MA1(PubMed)
(186) Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial by Badawy A¹, Abdel Aal I, Abulatta M.(PubMed)
(187) Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic  ovarian syndrome: a prospective randomized trial by Badawy A¹, Mosbah A, Shady M.(PubMed)
(188) Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome by Eckmann KR¹, Kockler DR.(PubMed)
(189) Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation by Seyedoshohadaei F¹, Zandvakily F¹, Shahgeibi S¹.(PubMed)
(190) Progress of integrative Chinese and Western medicine in treating polycystic ovarian syndrome caused infertility by Song JJ1, Yan ME, Wu XK, Hou LH.(PubMed)
(191) Chinese herbal medicine for subfertile women with polycystic ovarian syndrome by Zhang J1, Li T, Zhou L, Tang L, Xu L, Wu T, Lim DC.(PubMed)
(192) Comprehensive clinical management of polycystic ovary syndrome by Setji TL1, Brown AJ.(PubMed)
(193) Polycystic ovary syndrome by Kahn JA1, Gordon CM.(PubMed)
(194) Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study by West S1, Lashen H2, Bloigu A3, Franks S4, Puukka K5, Ruokonen A5, Järvelin MR6, Tapanainen JS7, Morin-Papunen L8.(PubMed)
(195) Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome by Al-Zubeidi H, Klein KO.(PubMed)
(196) The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome by Kaya MG1, Calapkorur B, Karaca Z, Yildirim S, Celik A, Akpek M, Unluhizarci K, Kelestimur F.(PubMed)
(197) Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings by Arentz S, Abbott JA, Smith CA, Bensoussan A.(PubMed)
(198) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(199) PCOS in adolescence and type 2 diabetes by Carreau AM1, Baillargeon JP.(PubMed)
(200) New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach. Ravn P1.(PubMed)
(201) Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers by Sharma ST1, Nestler JE.(PubMed)
(202) Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome. by Stabile G1, Borrielli I2, Artenisio AC1, Bruno LM1, Benvenga S1, Giunta L1, La Marca A3, Volpe A3, Pizzo A4.(PubMed)
(203) Insulin sensitizers in polycystic ovary syndrome by Pasquali R1, Gambineri A.(PubMed)
(204) [A meta-analysis on acupuncture treatment of polycystic ovary syndrome]. [Article in Chinese] by Ren LN, Guo LH, Ma WZ, Zhang R.(PubMed)
(205) [Effect of danzhi xiaoyao pill on ovulation induction of polycystic ovarian syndrome patients of pathogenic fire derived from stagnation of gan-qi]. [Article in Chinese] by Liu Y1, Mao LH.(PubMed)
(206) Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly by Kaltsas GA1, Androulakis II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G.(PubMed)
(207() Acromegaly presenting as hirsuitism: Uncommon sinister aetiology of a common clinical sign by Jain R1, Dutta D, Shivaprasad K, Maisnam I, Ghosh S, Mukhopadhyay S, Chowdhury S.(PubMed)
(208) Acromegaly(UCLA health)
(209) Aggressive tumors and difficult choices in acromegaly by Carrasco CA1, Gadelha M, Manavela M, Bruno OD.(PubMed)
(210) Acromegaly(NIH)
(211) Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study by Di Carlo C1, Gargano V, Sparice S, Tommaselli GA, Bifulco G, Nappi C.(PubMed) 

(211) Cardiovascular risk factors and events in women with androgen excess by Macut D¹, Antić IB, Bjekić-Macut J.(PubMed)

(212) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society by Wild RA¹, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA.(PubMed)

(213) Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced? by Tomlinson J¹, Millward A, Stenhouse E, Pinkney J.(PubMed)

(214) Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis by Stuckey BG¹, Opie N², Cussons AJ³, Watts GF⁴, Burke V⁴.(PubMed)

(215) Cardiac fatty acid uptake and metabolism in the rat model of polycystic ovary syndrome by Tepavčević S¹, Milutinović DV, Macut D, Stojiljković M, Nikolić M, Božić-Antić I, Ćulafić T, Bjekić-Macut J, Matić G, Korićanac G.(PubMed)

(216) Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome by Saranya K¹, Pal GK, Habeebullah S, Pal P.(PubMed)

(217) Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome by Bajuk Studen K¹, Jensterle Sever M, Pfeifer M.(PubMed)

(218) Risk of cardiovascular events in patients with polycystic ovary syndrome by Iftikhar S¹, Collazo-Clavell ML, Roger VL, St Sauver J, Brown RD Jr, Cha S, Rhodes DJ.(PubMed)

(220) Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis by Anderson SA¹, Barry JA¹, Hardiman PJ²(PubMed)

(221) Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study by Schmidt J¹, Landin-Wilhelmsen K, Brännström M, Dahlgren E.(PubMed)

(22) Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro by Piltonen TT¹, Chen JC², Khatun M³, Kangasniemi M³, Liakka A⁴, Spitzer T², Tran N², Huddleston H², Irwin JC², Giudice LC⁵.(PubMed)

(223) The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome - a proof-of-concept study by Shafiee MN¹, Malik DA, Yunos RI, Atiomo W, Omar MH, Ghani NA, Hatta AZ, Seedhouse C, Chapman C, Mokhtar NM.(PubMed)

(224) Micronized estradiol and progesterone therapy in primary, preinvasive endometrial cancer (1A/G1) in young women with polycystic ovarian syndrome by Stanosz S¹, von Mach-Szczypiński J, Sieja K, Koœciuszkiewicz J.(PubMed)

(225) The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern by Prakansamut N, Sirayapiwat P, Triratanachat S.(PubMed)

(226) PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma by Li X1, Shao R2(PubMed)

(227) Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential by Piltonen TT1, Chen J, Erikson DW, Spitzer TL, Barragan F, Rabban JT, Huddleston H, Irwin JC, Giudice LC.(PubMed)

(229) The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome - a proof-of-concept study by Shafiee MN1, Malik DA, Yunos RI, Atiomo W, Omar MH, Ghani NA, Hatta AZ, Seedhouse C, Chapman C, Mokhtar NM.(PubMed)

(230) Micronized estradiol and progesterone therapy in primary, preinvasive endometrial cancer (1A/G1) in young women with polycystic ovarian syndrome by Stanosz S1, von Mach-Szczypiński J, Sieja K, Koœciuszkiewicz J.(PubMed)

(231) Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia by Cicero AF1, Reggi A, Parini A, Morbini M, Rosticci M, Grandi E, Borghi C.(PubMed)

(232) Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome by Falsetti L1, Pasinetti E.(PubMed)

(233) Polycystic Ovary Syndrome and the Metabolic Syndrome by Julie L. Sharpless, MD(American diabeyes association)

(234) Pathophysiology and types of dyslipidemia in PCOS by Diamanti-Kandarakis E1, Papavassiliou AG, Kandarakis SA, Chrousos GP(PubMed)

(235) Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies? by Meirow D1, Raz I, Yossepowitch O, Brzezinski A, Rosler A, Schenker JG, Berry EM.(PubMed)

(236) Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study by Løvvik TS1, Wikström AK, Neovius M, Stephansson O, Roos N, Vanky E.(PubMed)

(237) [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI]. [Article in Russian] [No authors listed](PubMed)

(238) N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials byThakker D1, Raval A2, Patel I3, Walia R4.(PubMed)

(239) Aromatase inhibitors for subfertile women with polycystic ovary syndrome by Franik S1, Kremer JA, Nelen WL, Farquhar C.(PubMed)

(240) Chinese herbal medicine for female infertility: an updated meta-analysis by Ried K1.(PubMed)

(241) Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates - a randomized trial by Shahin AY1, Mohammed SA.(PubMed)

(242) [Effect of danzhi xiaoyao pill on ovulation induction of polycystic ovarian syndrome patients of pathogenic fire derived from stagnation of gan-qi]. [Article in Chinese] by Liu Y1, Mao LH.(PubMed)

(243) Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins by Vollenhoven B1, Clark S, Kovacs G, Burger H, Healy D.(PubMed)

(244) Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome by Weerakiet S1, Srisombut C, Rojanasakul A, Panburana P, Thakkinstian A, Herabutya Y.(PubMed)

(245)

(246) The prevalence of polycystic ovaries in women with a history of gestational diabetes. Kousta E1, Cela E, Lawrence N, Penny A, Millauer B, White D, Wilson H, Robinson S, Johnston D, McCarthy M, Franks S.(PubMed)

(247) Reporting the rates of depression in polycystic ovary syndrome (PCOS) by Barry JA1, Kuczmierczyk AR, Hardiman PJ.(PubMed)

(248) Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women by Pastore LM1, Patrie JT, Morris WL, Dalal P, Bray MJ.(PubMed)

(249) Psychological aspects of the polycystic ovary syndrome by Farkas J1, Rigó A, Demetrovics Z.(PubMed)

(250) Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? by Deeks AA1, Gibson-Helm ME, Paul E, Teede HJ.(PubMed)

(251) Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis by Ramezani-Binabaj M1, Motalebi M2, Karimi-Sari H3, Rezaee-Zavareh MS1, Alavian SM4.(PubMed)

(252) Nonalcoholic fatty liver disease in women with polycystic ovary syndrome by  Cerda C1, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, Espinoza M, Pizarro M, Solis N, Miquel JF, Arrese M.(PubMed)

(253) [Prevalence of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome: a case-control study]. [Article in Chinese] by Zheng RH1, Ding CF.(PubMed)

(254) An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome by  Brzozowska MM1, Ostapowicz G, Weltman MD(PubMed)

(255)      (259)

(260) The Science of Stress, Bad Habits, and Risk of Chronic Diseases

(261) The risks of poor nutrition(SA health)

(262) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis by Murri M¹, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF.(PubMed)

(263) The reproductive phenotype in polycystic ovary syndrome by Chang RJ¹.(PubMed)

(264) Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential by Piltonen TT¹, Chen J, Erikson DW, Spitzer TL, Barragan F, Rabban JT, Huddleston H, Irwin JC, Giudice LC.(PubMed)

(265) Anti-inflammatory effects of plant-based foods and of their constituents by Watzl B¹.(PubMed)

(266) [Immunopathological responses in women with chronic inflammatory diseases of the uterus and appendages and their therapeutic correction].[Article in Russian] by Medvedev BI¹, Kazachkova EA, Kazachkov EL.(PubMed)

(267) Cross Talk Between ER Stress, Oxidative Stress, and Inflammation in Health and Disease by Dandekar A¹, Mendez R, Zhang K.(PubMed)

(268) New dog and new tricks: evolving roles for IL-33 in type 2 immunity by Lott JM¹, Sumpter TL¹, Turnquist HR².(PubMed)

(269) Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease by Harbige LS¹.(PubMed)

(270) Effect of conjugated linoleic Acid, vitamin e, alone or combined on immunity and inflammatory parameters in adults with active rheumatoid arthritis: a randomized controlled trial by Aryaeian N¹, Djalali M², Shahram F³, Djazayery A⁴, Eshragian MR⁵.(PubMed)

(271) Red wine may be used in the therapy of myocarditis by Chen CJ¹, Yu W, Wang W.(PubMed)

(272) High dietary fiber lowers systemic inflammation: potential utility in COPD and lung cancer by Young RP¹, Hopkins RJ².(PubMed)

(273) Dietary fibre linked to decreased inflammation in overweight minority youth by Miller SJ¹, Batra AK, Shearrer GE, House BT, Cook LT, Pont SJ, Goran MI, Davis JN.(PubMed)

(274) Effects of high-intensity blood flow restriction exercise on muscle fatigue by Neto GR1, Santos HH2, Sousa JB3, Júnior AT4,(PubMed)

(275) Influence of Blood Flow Restriction During Low-intensity Resistance Exercise on the Post-exercise Hypotensive Response by Maior AS1, Simão R, Rocha Martins MS, Freitas de Salles B, Willardson JM. Araújo JP3, Aniceto RR5, Sousa MS3.(PubMed)

(276) Impact of exercise on muscle and nonmuscle organs by Boström PA1, Graham EL, Georgiadi A, Ma X.(PubMed)

(277) Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation by Benatti FB1, Pedersen BK2.(PubMed)

(278) The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases by Brandt C1, Pedersen BK.(PubMed)

(279) Enhanced follicular dendritic cell-B cell interaction in HIV and SIV infections and its potential role in polyclonal B cell activation by Rosenberg YJ1, Lewis MG, Kosco-Vilbois MH.(PubMed)

(280) THE FATE OF THE GIANT CELLS IN HEALING TUBERCULOUS TISSUE, AS OBSERVED IN A CASE OF HEALING TUBERCULOUS MENINGITIS by Hektoen L1.(PubMed)

(281) Cell-mediated immunity to mouse tumors: some recent findings. Hellström KE, Hellström I.(PubMed)

(282) Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors by Ngiow SF1, von Scheidt B, Akiba H, Yagita H, Teng MW, Smyth MJ.(PubMed)

(283) Effects of a holistic yoga program on endocrine parameters in adolescents with polycystic ovarian syndrome: a randomized controlled trial by Nidhi R1, Padmalatha V, Nagarathna R, Amritanshu R.(PubMed)

(284) Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome byNidhi R1, Padmalatha V, Nagarathna R, Ram A.(PubMed)

(285) Food, Immunity, and the Microbiome by Tilg H¹, Moschen AR².(PubMed)

(285) Food, Immunity, and the Microbiome by Tilg H¹, Moschen AR².(PubMed)

(286) Edible mushrooms: improving human health and promoting quality life by Valverde ME¹, Hernández-Pérez T¹, Paredes-López O¹.(PubMed)

(287) [Effect of some vitamins on activity of immunocompetent cells].[Article in Russian]by Nezgovorov DV.(PubMed)

(288) Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air by Khan MT¹, van Dijl JM¹, Harmsen HJ¹.(PubMed)

(289) Storing red blood cells with vitamin C and N-acetylcysteine prevents oxidative stress-related lesions: a metabolomics overview by Pallotta V¹, Gevi F¹, D'alessandro A¹, Zolla L¹.(PubMed)

(290) Red blood cell metabolism under prolonged anaerobic storage by D'Alessandro A¹, Gevi F, Zolla L.(PubMed)

(291) Alterations in antioxidant defense system of workers chronically exposed to arsenic, cadmium and mercury from coal flying ash by Zeneli L¹, Sekovanić A, Ajvazi M, Kurti L, Daci N.(PubMed)

(292) Indomethacin-induced translocation of bacteria across enteric epithelia is reactive oxygen species-dependent and reduced by vitamin C by Schoultz I¹, McKay CM, Graepel R, Phan VC, Wang A, Söderholm J, McKay DM.(PubMed)

(293) Vitamin C derivative ascorbyl palmitate promotes ultraviolet-B-induced lipid peroxidation and cytotoxicity in keratinocytes by Meves A¹, Stock SN, Beyerle A, Pittelkow MR, Peus D.(PubMed)

(294). Effects of dried fish on antioxidant levels in rat liver by Anilakumar KR¹, Khanum F, Krishna KR, Viswanathan KR.(PubMed)

(295) Vitamin A and retinoic acid in T cell-related immunity by Ross AC¹.(PubMed)

(296) Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance by Cassani B¹, Villablanca EJ, De Calisto J, Wang S, Mora JR.(PubMed)

(297) Modulatory role of vitamin A on the Candida albicans-induced immune response in human monocytes by Klassert TE¹, Hanisch A, Bräuer J, Klaile E, Heyl KA, Mansour MK, Tam JM, Vyas JM, Slevogt H.(PubMed)

(298) [Toxicology of the synthetic antioxidants BHA and BHT in comparison with the natural antioxidant vitamin E].[Article in German]by Kahl R¹, Kappus H.(PubMed)

(299) Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants by Darr D¹, Dunston S, Faust H, Pinnell S.(PubMed)

(300) Immune dysfunction and cytokine production in hemodialysis. Could they be lessened by vitamin E-coated dialyzer membrane by Senatore M, Cecere P, Colombo P, Costantini L, Filiberti O, Piccini G, Peona C, Buemi M, Nicoletti A, Rizzuto G.(PubMed)

(301) Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction by Girndt M¹, Lengler S, Kaul H, Sester U, Sester M, Köhler H.(PubMed)

(302) Vitamin E and immunity by Moriguchi S¹, Muraga M.(PubMed)

(303) The role of vitamin E in T-cell differentiation and the decrease of cellular immunity with aging.by Moriguchi S¹.(PubMed)

(304) Evaluation of Relation between Anthropometric Indices and Vitamin D Concentrations in Women with Polycystic Ovarian Syndrome by Faraji R1, Sharami SH1, Zahiri Z1, Asgharni M1, Kazemnejad E1, Sadeghi S1.(PubMed)

(305) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed) (306)   (331)

(332) Effect of ginger on gastric motility and symptoms of functional dyspepsia by Hu ML¹, Rayner CK, Wu KL, Chuah SK, Tai WC, Chou YP, Chiu YC, Chiu KW, Hu TH.(PubMed)

(333) Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori by Pellicano R¹, Ribaldone DG, Saracco GM, Leone N, De Angelis C, Arrigoni A, Morello E, Sapone N, Cisarò F, Astegiano M.(PubMed)

(334) A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe) by Haniadka R¹, Saldanha E, Sunita V, Palatty PL, Fayad R, Baliga MS.(PubMed)

(335) Ginger in the prevention of nausea and vomiting: a review by Palatty PL¹, Haniadka R, Valder B, Arora R, Baliga MS.(PubMed)

(336) Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip by Drozdov VN¹, Kim VA, Tkachenko EV, Varvanina GG.(PubMed)

(337) Antiproliferative properties of Padma Lax and its components ginger and elecampane by Hofbauer S¹, Kainz V, Golser L, Klappacher M, Kiesslich T, Heidegger W, Krammer B, Hermann A, Weiger TM.(PubMed)

(338) The postulated mechanism of the protective effect of ginger on the aspirin induced gastric ulcer: Histological and immunohistochemical studies by Salah Khalil M¹.(PubMed)

(339) Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response by Khan AM¹, Shahzad M, Raza Asim MB, Imran M, Shabbir A.(PubMed)

(340) Effects of various fragrant ingredients on desmopressin-induced fluid retention in mice by Morimoto Y¹, Shibata Y.(PubMed)

(341) Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders by Ghayur MN¹, Gilani AH.(PubMed)

(342) Identification of serotonin 5-HT1A receptor partial agonists in ginger by Nievergelt A¹, Huonker P, Schoop R, Altmann KH, Gertsch J.(PubMed)

(343) Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice by Yi LT¹, Xu Q, Li YC, Yang L, Kong LD.(PubMed)

(344) Comparative effects of dietary ginger (Zingiber officinale) and garlic (Allium sativum) investigated in a type 2 diabetes model of rats by Islam MS¹, Choi H.(PubMed)

(345) The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes by Shidfar F, Rajab A, Rahideh T, Khandouzi N, Hosseini S, Shidfar S.(PubMed)

(346) Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition , by Benzie IFF, Wachtel-Galor S, editors. Boca Raton (FL): CRC Press; 2011.(PubMed)

(347) Anti-cancer activity of Ginger (Zingiber officinale) leaf through the expression of activating transcription factor 3 in human colorectal cancer cells by Park GH, Park JH, Song HM, Eo HJ, Kim MK, Lee JW, Lee MH, Cho KH, Lee JR, Cho HJ, Jeong JB¹.(PubMed)

(348) Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model by Bidinotto LT¹, Spinardi-Barbisan AL, Rocha NS, Salvadori DM, Barbisan LF.(PubMed)

(349) Gelam honey and ginger potentiate the anti cancer effect of 5-FU against HCT 116 colorectal cancer cells by Hakim L¹, Alias E, Makpol S, Ngah WZ, Morad NA, Yusof YA.(PubMed)

(350) Immunity: plants as effective mediators by Sultan MT¹, Butt MS, Qayyum MM, Suleria HA.(PubMed)

(351) 6-Shogaol inhibits chondrocytes' innate immune responses and cathepsin-K activity by Villalvilla A¹, da Silva JA, Largo R, Gualillo O, Vieira PC, Herrero-Beaumont G, Gómez R.(PubMed)

(352) Zingiber officinale: A Potential Plant against Rheumatoid Arthritis by Al-Nahain A¹, Jahan R², Rahmatullah M¹.(PubMed)

(353) Theoretical and experimental study on lipophilicity and wound healing activity of ginger compounds by Bakht MA¹, Alajmi MF², Alam P², Alam A³, Alam P³, Aljarba TM³.(PubMed)

(354) A Newly Designed Curcumin Analog Y20 Mitigates Cardiac Injury via Anti-Inflammatory and Anti-Oxidant Actions in Obese Rats by Qian Y¹, Zhong P², Liang D¹, Xu Z¹, Skibba M¹, Zeng C³, Li X¹, Wei T³, Wu L⁴, Liang G¹.(PubMed)

(355) Protective effects of various dosage of Curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus by Motaghinejad M¹, Karimian M², Motaghinejad O³, Shabab B⁴, Yazdani I⁵, Fatima S².(PubMed)

(356) Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats by Das KK¹, Razzaghi-Asl N, Tikare SN, Di Santo R, Costi R, Messore A, Pescatori L, Crucitti GC, Jargar JG, Dhundasi SA, Saso L.(PubMed)

(357) Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats by Rashid K¹, Sil PC².(PubMed)

(358) Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in vitro by Maier E¹, Kurz K, Jenny M, Schennach H, Ueberall F, Fuchs D.(PubMed)

(359) Gastroprotective effect of ethanolic extract of Curcuma xanthorrhiza leaf against ethanol-induced gastric mucosal lesions in Sprague-Dawley rats by Rahim NA¹, Hassandarvish P², Golbabapour S³, Ismail S⁴, Tayyab S⁴, Abdulla MA².(PubMed)

(360) Efficacy of contemporary and novel Intracanal medicaments against enterococcus faecalis by Marickar RF¹, Geetha RV², Neelakantan P¹.(PubMed)

(361) Novel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential: Development, in-vitro appraisal and in-vivo studies by El-Refaie WM¹, Elnaggar YS², El-Massik MA¹, Abdallah OY³(PubMed)

(363) Randomized double blind study of Curcuma domestica Val. for dyspepsia by Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, Theerapong S, Chantrakul C, Thanaveerasuwan T, Nimitnon  S, Boonroj P, Punkrut W, Gingsungneon V, et al.(PubMed)

(364) Effects of the extracts and an active compound curcumenone isolated from Curcuma zedoaria rhizomes on alcohol-induced drunkenness in mice by Kimura Y¹, Sumiyoshi M, Tamaki T.(PubMed)

(365) The evaluation of anti-ulcerogenic effect of rhizome starch of two source plants of Tugaksheeree (Curcuma angustifolia Roxb. and Maranta arundinacea Linn.) on pyloric ligated rats by Rajashekhara N¹, Ashok BK², Sharma PP³, Ravishankar B⁴.(PubMed)

(366) Clinical evaluation of an Indian polyherbal topical formulation in the management of eczema by Rawal RC¹, Shah BJ, Jayaraaman AM, Jaiswal V.(PubMed)

(367) Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis by Panahi Y¹, Hosseini MS², Khalili N², Naimi E², Majeed M³, Sahebkar A⁴.(PubMed)

(368) Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations by Nahar PP¹, Slitt AL, Seeram NP.(PubMed)

(369) Involvement of liver in diabetes mellitus: herbal remedies by Thent ZC¹, Das S¹.(PubMed)

(370) Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats by Kim HY¹, Okamoto T, Yokozawa T.(PubMed)

(371) Bactericidal activity of curcumin I is associated with damaging of bacterial membrane by Tyagi P¹, Singh M¹, Kumari H¹, Kumari A¹, Mukhopadhyay K¹.(PubMed)

(372) Antimicrobial activity of turmeric extract and its potential use in food industry by Gul P¹, Bakht J².(PubMed)

(373) Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol by Thavorn K¹, Mamdani MM, Straus SE.(PubMed)

(374) Curcumol Induces Apoptosis in SPC-A-1 Human Lung Adenocarcinoma Cells and Displays Anti-neoplastic Effects in Tumor Bearing Mice by Tang QL¹, Guo JQ, Wang QY, Lin HS, Yang ZP, Peng T, Pan XD, Liu B, Wang SJ, Zang LQ.(PubMed)

(375) Curcumol induces apoptosis via caspases-independent mitochondrial pathway in human lung adenocarcinoma ASTC-a-1 cells by Zhang W¹, Wang Z, Chen T.(PubMed)

(376) Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae--a review by Lu JJ¹, Dang YY, Huang M, Xu WS, Chen XP, Wang YT.(PubMed)

(377) In vitro Antioxidant Potential in Sequential Extracts of Curcuma caesia Roxb. Rhizomes by Reenu J¹, Azeez S¹, Bhageerathy C¹.(PubMed)

(378) Polyphenolic composition and antioxidant activities of 6 new turmeric (Curcuma longa L) accessions by Chinedum E¹, Kate E, Sonia C, Ironkwe A, Andrew I.(PubMed)

(379) Curcuma as a functional food in the control of cancer and inflammation by Schaffer M¹, Schaffer PM, Zidan J, Bar Sela G.(PubMed)

(380) Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice by Masuelli L¹, Benvenuto M, Fantini M, Marzocchella L, Sacchetti P, Di Stefano E, Tresoldi I, Izzi V, Bernardini R, Palumbo C, Mattei M, Lista F, Galvano F, Modesti A, Bei R.(PubMed)

(381) Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas by Zhang G¹, Miura Y, Yagasaki K.(PubMed)

(382) Antimutagenic and anticarcinogenic activity of tea polyphenols by Kuroda Y¹, Hara Y.(PubMed)

(383) High oolong tea consumption predicts future risk of diabetes among Japanese male workers: a prospective cohort study by Hayashino Y¹, Fukuhara S, Okamura T, Tanaka T, Ueshima H; HIPOP-OHP Research Group.(PubMed)

(384) Antihyperglycemic effect of oolong tea in type 2 diabetes by Hosoda K¹, Wang MF, Liao ML, Chuang CK, Iha M, Clevidence B, Yamamoto S.(PubMed)

(385) Beneficial effects of oolong tea consumption on diet-induced overweight and obese subjects by He RR¹, Chen L, Lin BH, Matsui Y, Yao XS, Kurihara H.(PubMed)

(386) Thermogenic ingredients and body weight regulation by Hursel R¹, Westerterp-Plantenga MS.(PubMed)

(387) Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity by Calabrese V¹, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ.(PubMed)

(388) The potential influence of plant polyphenols on the aging process by Cherniack EP¹.(PubMed)

(389) Antiallergic constituents from oolong tea stem by Ohmori Y¹, Ito M, Kishi M, Mizutani H, Katada T, Konishi H.(PubMed)

(390) [Effect of tea extracts, catechin and caffeine against type-I allergic reaction].[Article in Japanese] by Shiozaki T¹, Sugiyama K, Nakazato K, Takeo T.(PubMed)

(391) Antibacterial activity of Iranian green and black tea on streptococcus mutans: an in vitro study by Naderi NJ¹, Niakan M, Kharazi Fard MJ, Zardi S.(PubMed)

(392) Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas by Friedman M¹.(PubMed)

(393) Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols by Lin JK¹, Lin-Shiau SY.(PubMed)

(394) Polyphenol-enriched oolong tea increases fecal lipid excretion by Hsu TF¹, Kusumoto A, Abe K, Hosoda K, Kiso Y, Wang MF, Yamamoto S.(PubMed)

(395) Green and black tea consumption and risk of stroke: a meta-analysis by Arab L¹, Liu W, Elashoff D.(PubMed)

(396) Does tea affect cardiovascular disease? A meta-analysis by Peters U¹, Poole C, Arab L.(PubMed)

(397) Determination of tea components with antioxidant activity by Cabrera C¹, Giménez R, López MC.(PubMed)

(398) Structural determination and DPPH radical-scavenging activity of two acylated flavonoid tetraglycosides in oolong tea (Camellia sinensis) by Lee VS¹, Chen CR, Liao YW, Tzen JT, Chang CI.(PubMed)

(399) Evaluation of anti-inflammatory effects of green tea and black tea: A comparative in vitro study by Chatterjee P¹, Chandra S, Dey P, Bhattacharya S.(PubMed)

(400) Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells by Cavet ME¹, Harrington KL, Vollmer TR, Ward KW, Zhang JZ.(PubMed)

(401)  Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model by Kuo CL¹, Chen TS, Liou SY, Hsieh CC.(PubMed)

(402) Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications by Pae M¹, Wu D.(PubMed)

(403) Structure and inducing tumor cell apoptosis activity of polysaccharides isolated from Lentinus edodes by Wang KP¹, Zhang QL, Liu Y, Wang J, Cheng Y, Zhang Y.(PubMed)

(404) Polysaccharides from Tricholoma matsutake and Lentinus edodes enhance 5-fluorouracil-mediated H22 cell growth inhibition by Ren M, Ye L, Hao X, Ren Z, Ren S, Xu K, Li J.(PubMed)

(405) Structure and immuno-stimulating activities of a new heteropolysaccharide from Lentinula edodes by Xu X¹, Yan H, Zhang X.(PubMed)

(406) Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study by Choi JY, Paik DJ, Kwon DY, Park Y¹.(PubMed)

(407) Lentinus edodes: a macrofungus with pharmacological activities by Bisen PS¹, Baghel RK, Sanodiya BS, Thakur GS, Prasad GB.(PubMed)

(408) An examination of antibacterial and antifungal properties of constituents of Shiitake (Lentinula edodes) and oyster (Pleurotus ostreatus) mushrooms by Hearst R¹, Nelson D, McCollum G, Millar BC, Maeda Y, Goldsmith CE, Rooney PJ, Loughrey A, Rao JR, Moore JE.(PubMed)

(409) Antimicrobial properties of shiitake mushrooms (Lentinula edodes) by Rao JR, Smyth TJ, Millar BC, Moore JE.(PubMed)

(410) A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial by Gordon M¹, Bihari B, Goosby E, Gorter R, Greco M, Guralnik M, Mimura T, Rudinicki V, Wong R, Kaneko Y.(PubMed)

(411) A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3 by Gordon M¹, Guralnik M, Kaneko Y, Mimura T, Goodgame J, DeMarzo C, Pierce D, Baker M, Lang W.(PubMed)

(412) [Liver protective effect of Lentinula edodes mycelia(LEM)].[Article in Japanese] by Yagi K¹.(PubMed)

 (413) Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages by Gunawardena D¹, Bennett L, Shanmugam K, King K, Williams R, Zabaras D, Head R, Ooi L, Gyengesi E, Münch G.(PubMed)

(414) Effect of shiitake (Lentinus edodes) extract on antioxidant and inflammatory response to prolonged eccentric exercise by Zembron-Lacny A¹, Gajewski M, Naczk M, Siatkowski I.(PubMed)

(415) Both common and specialty mushrooms inhibit adhesion molecule expression and in vitro binding of monocytes to human aortic endothelial cells in a pro-inflammatory environment by Martin KR¹.(PubMed)

(416) Fumigation with essential oils improves sensory quality and enhanced antioxidant ability of shiitake mushroom (Lentinus edodes) by Jiang T¹, Luo Z², Ying T³.(PubMed)

(417) Antihyperlipidemic Effect of Dietary Lentinus edodes on Plasma, Feces and Hepatic Tissues in Hypercholesterolemic Rats by Yoon KN¹, Alam N, Lee JS, Cho HJ, Kim HY, Shim MJ, Lee MW, Lee TS.(PubMed)

(418) Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats by Fukushima M¹, Ohashi T, Fujiwara Y, Sonoyama K, Nakano M.(PubMed)

(419) Effects of Lentinus edodes mycelia on dietary-induced atherosclerotic involvement in rabbit aorta by Yamada T¹, Oinuma T, Niihashi M, Mitsumata M, Fujioka T, Hasegawa K, Nagaoka H, Itakura H.(PubMed)

(420) Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice by Inafuku M¹, Nagao K, Nomura S, Shirouchi B, Inoue N, Nagamori N, Nakayama H, Toda T, Yanagita T.(PubMed) 

(421) Trace Minerals and ImmunologyRichard C. Bull, Professor of Animal Sciences, University of Idaho

(422) Study of possible correlation between BLOOD IMMUNOGLOBULIN G INCREASED and MAGNESIUM CITRATE(Meds fact)

(423 )In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases by  Krause I¹, Wu R, Sherer Y, Patanik M, Peter JB, Shoenfeld Y.(PubMed)

(424) Effect of an injectable trace mineral supplement containing selenium, copper, zinc, and manganese on immunity, health, and growth of dairy calves by Teixeira AG¹, Lima FS¹, Bicalho ML¹, Kussler A¹, Lima SF¹, Felippe MJ¹, Bicalho RC².(PubMed)

(425) Effects of magnesium depletion on inflammation in chronic disease by Nielsen FH¹.(PubMed)

(426) Magnesium, inflammation, and obesity in chronic disease by Nielsen FH¹.(PubMed)

(427) Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance by Sharifi F¹, Mazloomi S, Hajihosseini R, Mazloomzadeh S.(PubMed)

(428) Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome by Kauffman RP¹, Tullar PE, Nipp RD, Castracane VD.(PubMed)

(429) Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation by Mertens K¹, Lowes DA¹, Webster NR¹, Talib J², Hall L², Davies MJ³, Beattie JH⁴, Galley HF⁵.(PubMed)

(430) Serum selenium concentration and antioxidant activity in cervical cancer patients before and after treatment by Subramanyam D¹, Subbaiah KV, Rajendra W, Lokanatha V.(PubMed)

(431) Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep3B by Baker RD¹, Baker SS, LaRosa K, Whitney C, Newburger PE.(PubMed)

(432) Selenium: biochemical role as a component of glutathione peroxidase by Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG.(PubMed)

(433) Selenium suppressed hydrogen peroxide-induced vascular smooth muscle cells calcification through inhibiting oxidative stress and ERK activation by Liu H¹, Lu Q, Huang K.(PubMed)

(434) Associations of obesity with prostate cancer risk differ between u.s. African-american and non-Hispanic white men: results from the selenium and vitamin e cancer prevention trial by Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, Lucia MS, Kristal AR.(PubMed)

(435) Selenium for preventing cancer by Vinceti M¹, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R, Del Giovane C.(PubMed)

(436) The association between selenium and lipid levels: a longitudinal study in rural elderly Chinese by Chen C¹, Jin Y¹, Unverzagt FW², Cheng Y¹, Hake AM³, Liang C¹, Ma F¹, Su L¹, Liu J¹, Bian J⁴, Li P⁵, Gao S⁶.(PubMed)

(437) Associations of selenium status with cardiometabolic risk factors: an 8-year follow-up analysis of the Olivetti Heart study by Stranges S¹, Galletti F, Farinaro E, D'Elia L, Russo O, Iacone R, Capasso C, Carginale V, De Luca V, Della Valle E, Cappuccio FP, Strazzullo P.(PubMed)

(438) Selenium status and blood lipids: the cardiovascular risk in Young Finns study by Stranges S¹, Tabák AG, Guallar E, Rayman MP, Akbaraly TN, Laclaustra M, Alfthan G, Mussalo-Rauhamaa H, Viikari JS, Raitakari OT, Kivimäki M.(PubMed)

(439) Influence of serum selenium concentrations on hypertension: the Lipid Analytic Cologne cross-sectional study by Berthold HK¹, Michalke B, Krone W, Guallar E, Gouni-Berthold I(PubMed)

(440) Serum selenium concentrations and hypertension in the US Population by Laclaustra M¹, Navas-Acien A, Stranges S, Ordovas JM, Guallar E.(PubMed)

(441) The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities by Huang Z¹, Rose AH, Hoffmann PR.(PubMed)

(442) The influence of selenium on immune responses by Hoffmann PR¹, Berry MJ.(PuMed)

(443) Selenium containing heterocycles: synthesis, anti-inflammatory, analgesic and anti-microbial activities of some new 4-cyanopyridazine-3(2H)selenone derivatives by Abdel-Hafez ShH¹.(PubMed)

(444) Antimicrobial selenium nanoparticle coatings on polymeric medical devices by Tran PA¹, Webster TJ.(PubMed)

(445) Selenium and selenoproteins in inflammatory bowel diseases and experimental colitis by Speckmann B¹, Steinbrenner H.(PubMed)

(446) Selenium, selenoproteins and human health: a review by Brown KM¹, Arthur JR.(PubMed)

(447) Zinc and the immune system by Rink L1, Gabriel P.(PubMed)

(448) The immune system and the impact of zinc during aging by Haase H1, Rink L.(PubMed)

(449) Some new nano-structure zinc(II) coordination compounds of an imidazolidine Schiff base: spectral, thermal, antimicrobial properties and DNA interaction. Montazerozohori M1, Musavi SA2, Naghiha A3, Zohour MM4.(PubMed)

(450) Candida article zinc and metallothionein(Cure zone)

(451) Metallothionein as an Anti-Inflammatory Mediator(Mediators of inflammation) 

(452) Zinc and its role in immunity and inflammation by Bonaventura P¹, Benedetti G¹, Albarède F², Miossec P³.(PubMed)

(453) Zinc: role in immunity, oxidative stress and chronic inflammation by Prasad AS1(PubMed)

(454) Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength by Hojyo S¹, Miyai T², Fujishiro H³, Kawamura M⁴, Yasuda T⁵, Hijikata A⁶, Bin BH⁷, Irié T⁸, Tanaka J⁸, Atsumi T⁹, Murakami M⁹, Nakayama M¹⁰, Ohara O¹¹, Himeno S³, Yoshida H⁵, Koseki H¹², Ikawa T¹³, Mishima K⁸, Fukada T14(PubMed)

(455) Frequency of autoallergy to manganese superoxide dismutase in atopic dermatitis patients: experience of three Italian dermatology centers by Guarneri F¹, Costa C, Foti C, Hansel K, Guarneri C, Guarneri B, Lisi P, Stingeni L.(PubMed)

(456) IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis by Schmid-Grendelmeier P¹, Flückiger S, Disch R, Trautmann A, Wüthrich B, Blaser K, Scheynius A, Crameri R.(PubMed)

(457) Manganese accumulation in bone following chronic exposure in rats: steady-state concentration and half-life in bone by O'Neal SL¹, Hong L¹, Fu S¹, Jiang W¹, Jones A¹, Nie LH¹, Zheng W².(PubMed)

(458) A compact DD neutron generator-based NAA system to quantify manganese (Mn) in bone in vivo by Liu Y¹, Byrne P, Wang H, Koltick D, Zheng W, Nie LH.(PubMed)

(459) Role of metal cofactors in enzyme regulation. Differences in the regulatory properties of the Escherichia coli nicotinamide adenine dinucleotide phosphate specific malic enzyme, depending on whether magnesium ion or manganese ion serves as divalent cation by Brown DA, Cook RA.(PubMed)

(450) Antioxidants and NOS inhibitors selectively targets manganese-induced cell volume via Na-K-Cl cotransporter-1 in astrocytes by Alahmari KA¹, Harini P², Prabhakaran K³, Chandramoorthy HC⁴, Ramakrishnan R⁵.(PubMed)

(451) Antioxidant effect of manganese by Coassin M¹, Ursini F, Bindoli A.(PubMed)

(452) Manganese supplementation protects against diet-induced diabetes in wild type mice by enhancing insulin secretion by Lee SH¹, Jouihan HA, Cooksey RC, Jones D, Kim HJ, Winge DR, McClain DA.(PubMed)

(453) Manganese-Mediated MRI Signals Correlate With Functional β-Cell Mass During Diabetes Progression by Meyer A¹, Stolz K¹, Dreher W², Bergemann J¹, Holebasavanahalli Thimmashetty V², Lueschen N¹, Azizi Z¹, Khobragade V¹, Maedler K³, Kuestermann E².(PubMed)

(454) Essential elements in depression and anxiety. Part II by Młyniec K¹, Gaweł M², Doboszewska U³, Starowicz G⁴, Pytka K⁵, Davies CL⁶, Budziszewska B⁷.(PubMed)

(455) Effect of antioxidant mineral elements supplementation in the treatment of hypertension in albino rats by Muhammad SA¹, Bilbis LS, Saidu Y, Adamu Y.(PubMed)

(456) Manganese supplementation reduces the blood cholesterol levels in Ca-deficient ovariectomized rats by Bae YJ¹, Choi MK, Kim MH.(PubMed)

(457) BOVINE INFERTILITY--RESPONSE TO MANGANESE THERAPY by WILSON JG.(PubMed)

(458)Pharmaceutical effect of manganese porphyrins on manganese superoxide dismutase deficient mice by Hayakawa N¹, Asayama S, Noda Y, Shimizu T, Kawakami H.(PubMed)

(459) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease by Dumont M¹, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT.(PubMed)

(460) Nutritional immunity beyond iron: a role for manganese and zinc by Kehl-Fie TE¹, Skaar EP.(PubMed)

(461) Genetic factors and manganese-induced neurotoxicity. by Chen P¹, Parmalee N¹, Aschner M¹.(PubMed)

(462) Manganese neurotoxicity: a focus on glutamate transporters by Karki P, Lee E, Aschner M¹.(PubMed)

(463) HEMOGLOBIN PRODUCTION IN ANEMIA LIMITED BY LOW PROTEIN INTAKE : INFLUENCE OF IRON INTAKE, PROTEIN SUPPLEMENTS AND FASTING by Hahn PF¹, Whipple GH.(PubMed)

(464) Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients by Coban E¹, Ozdogan M, Timuragaoglu A.(PubMed)

(465) Low serum levels of zinc, copper, and iron as risk factors for osteoporosis: a meta-analysis by Zheng J¹, Mao X, Ling J, He Q, Quan J.(PubMed)

(466) Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus by Youdim MB¹.(PubMed)

(467) Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones by Peeling P¹, Dawson B, Goodman C, Landers G, Trinder D.(PubMed)

(468) Aggett PJ. Iron. In: Erdman JW, Macdonald IA, Zeisel SH, eds. Present Knowledge in Nutrition. 10th ed. Washington, DC: Wiley-Blackwell; 2012:506-20.

(469) Murray-Kolbe LE, Beard J. Iron. In: Coates PM, Betz JM, Blackman MR, et al., eds. Encyclopedia of Dietary Supplements. 2nd ed. London and New York: Informa Healthcare; 2010:432-8.

(470) Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function by Lakhal-Littleton S¹, Wolna M², Carr CA², Miller JJ², Christian HC², Ball V², Santos A³, Diaz R³, Biggs D³, Stillion R⁴, Holdship P⁵, Larner F⁵, Tyler DJ², Clarke K², Davies B³, Robbins PA².(PubMed)

(471) Effect of dietary iron loading on recognition memory in growing rats by Han M¹, Kim J¹.(PubMed)

(472) [Anaemia and iron deficiency in clinical practice:from cardiology to gastroenterology and beyond].

[Article in Czech] by Češka R.(PubMed)

(473) Iron and mechanisms of emotional behavior by Kim J¹, Wessling-Resnick M².(PubMed)

(474) Essential elements in depression and anxiety. Part I by Młyniec K¹, Davies CL², de Agüero Sánchez IG³, Pytka K⁴, Budziszewska B⁵, Nowak G⁶.(PubMed)

(475) Iron deficiency: an emerging therapeutic target in heart failure by Cohen-Solal A¹, Leclercq C², Deray G³, Lasocki S⁴, Zambrowski JJ⁵, Mebazaa A⁶, de Groote P⁷, Damy T⁸, Galinier M⁹.(PubMed)

(476) Effect of iron-deficiency anemia on cognitive skills and neuromaturation in infancy and childhood by Walter T¹.(PubMed)

 (479) Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding by Peuranpää P¹, Heliövaara-Peippo S, Fraser I, Paavonen J, Hurskainen R.(PubMed)

(480) Iron deficiency and fatigue in adolescent females with heavy menstrual bleeding by Wang W¹, Bourgeois T, Klima J, Berlan ED, Fischer AN, O'Brien SH.(PubMed)

(481) Iron at the interface of immunity and infection by Nairz M¹, Haschka D¹, Demetz E¹, Weiss G¹.(PubMed)

(482) Impact of iron deficiency anemia on cell-mediated and humoral immunity in children: A case control study by Das I¹, Saha K¹, Mukhopadhyay D², Roy S¹, Raychaudhuri G³, Chatterjee M², Mitra PK¹.(PubMed)

(483) Iron Supplementation Attenuates the Inflammatory Status of Anemic Piglets by Regulating Hepcidin by Pu Y¹, Guo B, Liu D, Xiong H, Wang Y, Du H.(PubMed)

(484) A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia by Guida C¹, Altamura S², Klein FA³, Galy B³, Boutros M⁴, Ulmer AJ⁵, Hentze MW⁶, Muckenthaler MU².(PubMed)

(485) Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia by Baumann Kurer S¹, Seifert B, Michel B, Ruegg R, Fehr J.(PubMed)

(486) Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron by Toblli JE¹, Di Gennaro F², Rivas C².(PubMed)

(487) Antimicrobial copper's potential.[No authors listed](PubMed)

(488) Effects of in-feed copper and tylosin supplementations on copper and antimicrobial resistance in fecal enterococci of feedlot cattle by Amachawadi RG¹, Scott HM, Aperce C, Vinasco J, Drouillard JS, Nagaraja TG.(PubMed)

(489) Copper and immunity by Percival SS¹.(PubMed)

(490) The immune system as a physiological indicator of marginal copper status? by Bonham M¹, O'Connor JM, Hannigan BM, Strain JJ.(PubMed)

(491) Molecular basis for antioxidant enzymes in mediating copper detoxification in the nematode Caenorhabditis elegans by Song S¹, Zhang X¹, Wu H¹, Han Y², Zhang J¹, Ma E¹, Guo Y².(PubMed)

(492) The effects of coadministration of dietary copper and zinc supplements on atherosclerosis, antioxidant enzymes and indices of lipid peroxidation in the cholesterol-fed rabbit by Alissa EM¹, Bahijri SM, Lamb DJ, Ferns GA.(PubMed)

(493) Is copper pro- or anti-inflammatory? A reconciling view and a novel approach for the use of copper in the control of inflammation by Berthon G1(PubMed)

(494) Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis by Yassin NZ¹, El-Shenawy SM¹, Abdel-Rahman RF¹, Yakoot M², Hassan M³, Helmy S⁴.(PubMed)

(495) Enhanced analgesic properties and reduced ulcerogenic effect of a mononuclear copper(II) complex with fenoprofen in comparison to the parent drug: promising insights in the treatment of chronic inflammatory diseases by Agotegaray M¹, Gumilar F², Boeris M³, Toso R³, Minetti A².(PubMed)

(496) Nutraceuticals of anti-inflammatory activity as complementary therapy for rheumatoid arthritis by Al-Okbi SY¹.(PubMed)

(497) Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus by Schlief ML¹, Gitlin JD.(PubMed)

(498) Effect of sex hormones on copper, zinc, iron nutritional status and hepatic lipid peroxidation in rats by Wachnik A¹, Biró G, Biró L, Korom M, Gergely A, Antal M.(PubMed)

(499) Copper-zinc superoxide dismutase deficiency impairs sperm motility and in vivo fertility by Garratt M¹, Bathgate R, de Graaf SP, Brooks RC.(PubMed)

(500)  Iron and copper in male reproduction: a double-edged sword by Tvrda E1, Peer R, Sikka SC, Agarwal A.(PubMed)

(501) Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction by Bousquet-Moore D1, Prohaska JR, Nillni EA, Czyzyk T, Wetsel WC, Mains RE, Eipper BA.(PubMed)

(502) Deficient copper concentrations in dried-defatted hepatic tissue from ob/ob mice: A potential model for study of defective copper regulation in metabolic liver disease by Church SJ1, Begley P1, Kureishy N1, McHarg S1, Bishop PN1, Bechtold DA2, Unwin RD3, Cooper GJ4.(PubMed)

(503) Update on anemia and neutropenia in copper deficiency by Lazarchick J1.(PubMed)

(504) Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease by Brewer GJ¹.(PubMed)

(505) Alzheimer's disease causation by copper toxicity and treatment with zinc by Brewer GJ1(PubMed)

(506) The role of oxidative stress and antioxidants in male fertility by Walczak-Jedrzejowska R¹, Wolski JK², Slowikowska-Hilczer J¹.(PubMed)

(507) Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease by Kwak MS1, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, Yoon JH, Lee HS.(PubMed)

(508) Antioxidant status in patients with psoriasis by Nemati H, Khodarahmi R, Sadeghi M, Ebrahimi A, Rezaei M, Vaisi-Raygani A.(PubMed)

(509) Serum Bilirubin and Disease Progression in Mild Chronic Obstructive Pulmonary Disease by Apperley S, Park HY, Holmes DT, Man SF, Tashkin D, Wise RA, Connett JE, Sin DD.(PubMed)(510) Cellular-mediated immune responses in the liver tissue of patients with severe Plasmodiumfalciparum malaria by Punsawadl C, Setthapramote C, Viriyavejakul P.(PubMed)

(511) Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration by Bulmer AC1, Coombes JS, Blanchfield JT, Toth I, Fassett RG, Taylor SM.(PubMed)

(512) Bilirubin and related tetrapyrroles inhibit food-borne mutagenesis: a mechanism for antigenotoxic action against a model epoxide by Mölzer C1, Huber H, Steyrer A, Ziesel GV, Wallner M, Hong HT, Blanchfield JT, Bulmer AC, Wagner KH.(PubMed)

(513) Confocal laser scanning microscopy detection of chlorophylls and carotenoids in chloroplasts and chromoplasts of tomato fruit by D'Andrea L1, Amenós M, Rodríguez-Concepción M.(PubMed)

(514) Carotenoids(Wikipedia)

(515) Lycopene Inhibits the Isomerization of β-Carotene during Quenching of Singlet Oxygen and Free Radicals by Heymann T¹, Heinz P¹, Glomb MA¹.(PubMed)

(516) Wood smoke particles generate free radicals and cause lipid peroxidation, DNA damage, NFkappaB activation and TNF-alpha release in macrophages by Leonard SS¹, Wang S, Shi X, Jordan BS, Castranova V, Dubick MA.(PubMed)

(517) The Effects of Babesiosis on Oxidative Stress and DNA Damage in Anatolian Black Goats Naturally Infected with Babesia ovis by Kucukkurt I¹, Cigerci IH², Ince S³, Kozan E⁴, Aytekin I⁵, Eryavuz A⁶, Fidan AF¹.(PubMed)

(518) Beta-carotene and lung cancer in smokers: review of hypotheses and status of research by Goralczyk R¹.(PubMed)

(519) Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands by Tanvetyanon T¹, Bepler G.(PubMed)

(520) Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature by Petrick JL¹, Li N¹, McClain KM¹, Steck SE², Gammon MD³.(PubMed)

(521) Short- and long-term beta-carotene supplementation do not influence T cell-mediated immunity in healthy elderly persons by Santos MS¹, Leka LS, Ribaya-Mercado JD, Russell RM, Meydani M, Hennekens CH, Gaziano JM, Meydani SN.(PubMed)

(522) A and beta-carotene concentrations in adults with HIV/AIDS on highly active antiretroviral therapy by Kaio DJ¹, Rondó PH, Souza JM, Firmino AV, Luzia LA, Segurado AA.(PubMed)

(523) Plasma antioxidant levels in chronic cholestatic liver diseases by Floreani A¹, Baragiotta A, Martines D, Naccarato R, D'odorico A.(PubMed)

(524) Use of antioxidants to treat pain in chronic pancreatitis.[Article in English, Spanish by De las Heras Castaño G¹, García de la Paz A, Fernández MD, Fernández Forcelledo JL.(PubMed)

(525) Functional nutraceutical profiling of wild edible and medicinal mushrooms consumed by ethnic tribes in India by Khaund P¹, Joshi SR¹.(PubMed)

(526)Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular cares. by Ciccone MM¹, Cortese F¹, Gesualdo M¹, Carbonara S¹, Zito A¹, Ricci G¹, De Pascalis F¹, Scicchitano P¹, Riccioni G².(PubMed)

(527) Carotenoids and cardiovascular risk by Giordano P¹, Scicchitano P, Locorotondo M, Mandurino C, Ricci G, Carbonara S, Gesualdo M, Zito A, Dachille A, Caputo P, Riccardi R, Frasso G, Lassandro G, Di Mauro A, Ciccone MM.(PubMed)

(528) Supplementation of a low-carotenoid diet with tomato or carrot juice modulates immune functions in healthy men by Watzl B¹, Bub A, Briviba K, Rechkemmer G.(PubMed)

(529) Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection by Tohill BC¹, Heilig CM, Klein RS, Rompalo A, Cu-Uvin S, Piwoz EG, Jamieson DJ, Duerr A.(PubMed)

(530) Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation by Karppi J¹, Kurl S, Mäkikallio TH, Ronkainen K, Laukkanen JA.(PubMed)

(531)Adolescent carotenoid intake and benign breast disease by Boeke CE¹, Tamimi RM², Berkey CS³, Colditz GA⁴, Eliassen AH², Malspeis S⁵, Willett WC⁶, Frazier AL⁷.(PubMed)

(532) Dietary carotenoids and risk of breast cancer in Chinese women by Huang JP¹, Zhang M, Holman CD, Xie X.(PubMed)

(533) Effect of carotenoid β-cryptoxanthin on cellular and humoral immune response in rabbit by Ghodratizadeh S¹, Kanbak G, Beyramzadeh M, Dikmen ZG, Memarzadeh S, Habibian R.(PubMed)

(534) beta-Carotene and beta-cryptoxanthin but not lutein evoke redox and immune changes in RAW264 murine macrophages by Katsuura S¹, Imamura T, Bando N, Yamanishi R.(PubMed)

(535) β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice by Kobori M¹, Ni Y², Takahashi Y¹, Watanabe N¹, Sugiura M³, Ogawa K⁴, Nagashimada M⁵, Kaneko S⁶, Naito S¹, Ota T².(PubMed)

(536) Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin by Ni Y¹, Nagashimada M, Zhan L, Nagata N, Kobori M, Sugiura M, Ogawa K, Kaneko S, Ota T.(PubMed)

(537) The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence by García-Closas R¹, Castellsagué X, Bosch X, González CA.(PubMed)

(538) The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells by Lorenzo Y¹, Azqueta A, Luna L, Bonilla F, Domínguez G, Collins AR.(PubMed)

(539) Antiproliferative activity of Cyanophora paradoxa pigments in melanoma, breast and lung cancer cells by Baudelet PH¹, Gagez AL, Bérard JB, Juin C, Bridiau N, Kaas R, Thiéry V, Cadoret JP, Picot L.(PubMed)

(540) Dietary carotenoids and risk of breast cancer in Chinese women by Huang JP¹, Zhang M, Holman CD, Xie X.(PubMed)

(541) Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies by Chen J¹, Song Y, Zhang L.(PubMed)

(542) The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies by Etminan M¹, Takkouche B, Caamaño-Isorna F.(PubMed)

(543) The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity by Linnewiel-Hermoni K¹, Khanin M¹, Danilenko M¹, Zango G¹, Amosi Y¹, Levy J¹, Sharoni Y².(PubMed)

(544) Inhibitory effects of combination of lycopene and genistein on 7,12- dimethyl benz(a)anthracene-induced breast cancer in rats by Sahin K¹, Tuzcu M, Sahin N, Akdemir F, Ozercan I, Bayraktar S, Kucuk O.(PubMed)

(545) Lycopene and beta-carotene induce cell-cycle arrest and apoptosis in human breast cancer cell lines by Gloria NF¹, Soares N, Brand C, Oliveira FL, Borojevic R, Teodoro AJ.(PubMed)

(546) Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention by Ip BC¹, Wang XD².(PubMed)

(547) Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis by Bernal C¹, Martín-Pozuelo G, Lozano AB, Sevilla A, García-Alonso J, Canovas M, Periago MJ.(PubMed)

(548) Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N'-nitro-N-nitrosoguanidine-enduced gastric cancer rats by Luo C¹, Wu XG.(PubMed)

(549) Anti-aging effect of Blakeslea trispora powder on adult mice by Hu W¹, Dai D, Li W.(PubMed)

(550) The effects of lycopene on DNA damage and oxidative stress on indomethacin-induced gastric ulcer in rats by Boyacioglu M¹, Kum C², Sekkin S², Yalinkilinc HS², Avci H³, Epikmen ET³, Karademir U².(PubMed)

(551) Beneficial effect of lycopene on anti-diabetic nephropathy through diminishing inflammatory response and oxidative stress by Guo Y¹, Liu Y, Wang Y.(PubMed)

(552) Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors by Pall ML¹, Levine S².(PubMed) 

(553) THE HIERARCHY OF FLAVONOID ANTIOXIDANT POTENTIALS/2003 Nita Bishop, N.D. Presented ! at AANP (American ! Association of ! Naturopathic Physicians) Convention 2003 ! in Portland, ! Oregon

(554) Apoptosis Induction by the Total Flavonoids from Arachniodes exilis in HepG2 Cells through Reactive Oxygen Species-Mediated Mitochondrial Dysfunction Involving MAPK Activation by Li H¹, Chen J², Xiong C², Wei H², Yin C³, Ruan J².(PubMed)

(555) Tissue injury by reactive oxygen species and the protective effects of flavonoids by de Groot H¹, Rauen U.(PubMed)

(556) Antioxidant activity of flavonoids: efficiency of singlet oxygen (1 delta g) quenching by Tournaire C¹, Croux S, Maurette MT, Beck I, Hocquaux M, Braun AM, Oliveros E.(PubMed)

(557) Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation by Ozyürek M¹, Bektaşoğlu B, Güçlü K, Apak R.(PubMed)

(558) Phytochemicals and their potential usefulness in inflammatory bowel disease by Somani SJ¹, Modi KP, Majumdar AS, Sadarani BN.(PubMed)

(559) Kolaviron, a biflavonoid complex of Garcinia kola seeds modulates apoptosis by suppressing oxidative stress and inflammation in diabetes-induced nephrotoxic rats by Ayepola OR¹, Cerf ME², Brooks NL³, Oguntibeju OO⁴.(PubMed)

(560) Nitric oxide and peroxynitrite in health and disease by Pacher P¹, Beckman JS, Liaudet L.(PubMed)

(561) The effects of nitric oxide on the immune system during Trypanosoma cruzi infection by Gutierrez FR¹, Mineo TW, Pavanelli WR, Guedes PM, Silva JS.(PubMed)

(562) Flavonoids in prevention of diseases with respect to modulation of Ca-pump function by Lubica Horáková(PubMed)

(563) Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages by Hämäläinen M¹, Nieminen R, Vuorela P, Heinonen M, Moilanen E.(PubMed)

(564) The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells by García-Mediavilla V¹, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, Tuñón MJ, González-Gallego J.(PubMed)

(565) Plasma metabolites of quercetin and their antioxidant properties by Morand C¹, Crespy V, Manach C, Besson C, Demigné C, Rémésy C.(PubMed)

(566) Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin by Dueñas M¹, González-Manzano S, González-Paramás A, Santos-Buelga C.(PubMed)

(567) Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study by Huk I¹, Brovkovych V, Nanobash Vili J, Weigel G, Neumayer C, Partyka L, Patton S, Malinski T.(PubMed)

(568) Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats by Ghosh A¹, Sarkar S, Mandal AK, Das N.(PubMed)

(569) Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo by Oršolić N¹, Car N.(PubMed)

(570) The effect of quercetin on oxidative DNA damage and myelosuppression induced by etoposide in bone marrow cells of rats by Papież MA¹.(PubMed)

(571) Effect of Scutia buxifolia Reissek in nucleotidase activities and inhibition of platelet aggregation by Boligon AA¹, Pimentel VC, Bagatini MD, Athayde ML.(PubMed)

(572) [Effect of rutin (rutinion) on capillary permeability].[Article in Undetermined Language] by BLAICH W, TUSHAUS B.(PubMed)

(573) Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids by Jeong YJ¹, Choi YJ, Kwon HM, Kang SW, Park HS, Lee M, Kang YH.(PubMed)

(574) The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic  painful peripheral neuropathy by Azevedo MI, Pereira AF, Nogueira RB, Rolim FE, Brito GA, Wong DV, Lima-Júnior RC, de Albuquerque Ribeiro R, Vale ML¹.(PubMed)

(575) Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion by Qu J¹, Zhou Q, Du Y, Zhang W, Bai M, Zhang Z, Xi Y, Li Z, Miao J.(PubMed)

(576) Anti-inflammatory and antioxidative effects of the methanolic extract of the aerial parts of Mitracarpus frigidus in established animal models by Fabri RL¹, Garcia RA, Florêncio JR, de Castro Campos Pinto N, de Oliveira LG, Aguiar JA, Ribeiro A, Scio E.(PubMed)

(577) Synergistic antioxidant effect of catechin and malvidin 3-glucoside on free radical-initiated peroxidation of linoleic acid in micelles by Rossetto M¹, Vanzani P, Mattivi F, Lunelli M, Scarpa M, Rigo A.(PubMed)

(578) Protective role of oligonol from oxidative stress-induced inflammation in C6 glial cell by Ahn JH¹, Choi JW¹, Choi JM¹, Maeda T², Fujii H², Yokozawa T³, Cho EJ¹.(PubMed)

(579) Catechins: natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1) by Costa S¹, Utan A, Cervellati R, Speroni E, Guerra MC.(PubMed)

(580) Periodontal pathogens and atherosclerosis: implications of inflammation and oxidative modification of LDL by Kurita-Ochiai T¹, Yamamoto M¹.(PubMed)

(581) UP446, analgesic and anti-inflammatory botanical composition by Yimam M¹, Brownell L, Pantier M, Jia Q.(PubMed)

(582) In vitro anti-inflammatory activity of phenolic rich extracts from white and red common beans by García-Lafuente A¹, Moro C², Manchón N², Gonzalo-Ruiz A³, Villares A², Guillamón E², Rostagno M², Mateo-Vivaracho L².(PubMed)

(583) A combination of lipoic acid plus coenzyme Q10 induces PGC1α, a master switch of energymetabolism, improves stress response, and increases cellular glutathione levels in cultured C2C12 skeletal muscle cells by Wagner AE¹, Ernst IM, Birringer M, Sancak O, Barella L, Rimbach G.(PubMed)

(584) Coenzyme q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxdiation in chronic gastritis associated with H. pylori infection by Rahmani A¹, Abangah G, Moradkhani A, Hafezi Ahmadi MR, Asadollahi K.(PubMed)

(585) Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes by Hodgson JM¹, Watts GF, Playford DA, Burke V, Croft KD.(PubMed)

(586) The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study by Mezawa M¹, Takemoto M, Onishi S, Ishibashi R, Ishikawa T, Yamaga M, Fujimoto M, Okabe E, He P, Kobayashi K, Yokote K.(PubMed)

(587) Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness by Maes M¹, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.(PubMed)

(588) Coenzyme Q10 in cardiovascular disease by Pepe S¹, Marasco SF, Haas SJ, Sheeran FL, Krum H, Rosenfeldt FL.(PubMed)

(589) Coenzyme Q10 for Parkinson's disease by Liu J¹, Wang L, Zhan SY, Xia Y.(PubMed)

(590) The Effect of Creatine and Coenzyme Q10 Combination Therapy on Mild Cognitive Impairment in Parkinson's Disease by Li Z¹, Wang P, Yu Z, Cong Y, Sun H, Zhang J, Zhang J, Sun C, Zhang Y, Ju X.(PubMed)

(591) Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome by El Refaeey A¹, Selem A², Badawy A³.(PubMed)

(592)  (595)

(596) Anti-inflammatory effect of tanshinone I in neuroprotection against cerebral ischemia-reperfusion injury in the gerbil hippocampus by Park JH¹, Park Ok, Cho JH, Chen BH, Kim IH, Ahn JH, Lee JC, Yan BC, Yoo KY, Lee CH, Hwang IK, Kwon SH, Lee YL, Won MH, Choi JH.(PubMed)

(597) Blocking of JB6 cell transformation by tanshinone IIA: epigenetic reactivation of Nrf2 antioxidative stress pathway by Wang L¹, Zhang C, Guo Y, Su ZY, Yang Y, Shu L, Kong AN.(PubMed)

(598) In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid β-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors by Zhou Y¹, Li W, Xu L, Chen L.(PubMed)

(599) Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis by Chen Z¹, Xu H².(PubMed)

(600) The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy by Pang H¹, Han B¹, Yu T¹, Peng Z².(PubMed)

(601) [Effects of cryptotanshinone in lowering androgens synthesis for the prenatally androgenized male rats].[Article in Chinese] by Li XH¹, Yang XM, Wu XK.(PubMed)

(602)  Xing J, Zhang Y, Hu M, et al. Tanshinone effect on the expression of IRS-1 and p-ERK in trophoblastic cells under insulin resistance. Sci Technol Rev 2009;27:75–9

(603) Yan M, Yang L, Wu X. Effects of insulin-sensitizing agents on insulin resistance of porcine granulosa cells. Sci Technol Rev 2008;26:77–81 

(604)Effects of tanshinone on hyperandrogenism and the quality of life in women with polycystic ovary syndrome: protocol of a double-blind, placebo-controlled, randomised trial by Wenjuan Shen,¹ Yuehui Zhang,¹ Wei Li,¹ Jing Cong,¹ Ying Zhou,² Ernest H Y Ng,³ and Xiaoke Wu.(PubMed)

 (605) Birdsall TC, Kelly GS (1997). "Berberine: Therapeutic potential of an alkaloid found in several medicinal plants" (PDF). Alternative Medicine Reviews 2 (2): 94–103.

(606)Gibbs PJ, Seddon KR (April 2000). "Berberine". Alternative Medicine Review (British Library) 5 (2): 175–7. ISBN 0-7123-0649-8. PMID 10767672. 

(607) Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori by Chang CH¹, Huang WY, Lai CH, Hsu YM, Yao YH, Chen TY, Wu JY, Peng SF, Lin YH.(PubMed)

(608) Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial by Ball AR¹, Casadei G, Samosorn S, Bremner JB, Ausubel FM, Moy TI, Lewis K.(PubMed)

(609) Berberine, a potential drug for trachoma.[Article in English, French] by Khosla PK¹, Neeraj VI, Gupta SK, Satpathy G.(PubMed)

(610) Antifungal, Antileishmanial, and Cytotoxicity Activities of Various Extracts of Berberis vulgaris (Berberidaceae) and Its Active Principle Berberine by Mahmoudvand H¹, Ayatollahi Mousavi SA², Sepahvand A³, Sharififar F⁴, Ezatpour B⁵, Gorohi F⁶, Saedi Dezaki E², Jahanbakhsh S¹.(PubMed)

(611) Application of berberine on treating type 2 diabetes mellitus by Pang B¹, Zhao LH², Zhou Q³, Zhao TY¹, Wang H¹, Gu CJ¹, Tong XL¹.(PubMed)

(612) Efficacy of berberine in patients with type 2 diabetes mellitus by Yin J¹, Xing H, Ye J.(PubMed)

(613) The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet by Chang XX¹, Yan HM, Xu Q, Xia MF, Bian H, Zhu TF, Gao X.(PubMed)

(614) Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption by Wang Y¹, Yi X², Ghanam K², Zhang S³, Zhao T³, Zhu X³.(PubMed)

(615) Nutraceuticals for treatment of high blood pressure values in patients with metabolic syndrome by Rozza F¹, de Simone G, Izzo R, De Luca N, Trimarco B.(PubMed)

(616)  Cheng Z, Guo S, Copps K, Dong X, Kollipara R, Rodgers JT et al. (November 2009). "Foxo1 integrates insulin signaling with mitochondrial function in the liver". Nature Medicine 15 (11): 1307–11. doi:10.1038/nm.2049. PMID 19838201.

(617)Akt signaling is associated with the berberine-induced apoptosis of human gastric cancer cells by Yi T¹, Zhuang L, Song G, Zhang B, Li G, Hu T.(PubMed)

(618) Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism by Wang N¹, Feng Y, Zhu M, Tsang CM, Man K, Tong Y, Tsao SW(PubMed)

(619) Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL by Hsu WH¹, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH.(PubMed)

(620) A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome by Wei W, Zhao H, Wang A by Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y.(PubMed)

(621) Effect of Berberine on Hormonal and Metabolic Features in Obese Women With Polycystic Ovary Syndrome (PCOS)14:32 EST 15th January 2014 | BioPortfolio

(622) Developmental toxicity evaluation of berberine in rats and mice by Jahnke GD, Price CJ, Marr MC, Myers CB, George JD.(PubMed) 

 (623) Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review.

Peitsidis P¹, Agrawal R.(PubMed)

(624) Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.

Agrawal R¹, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J, Tan SL, Campbell S, Jacobs HS.(PubMed)

(625) Effect of curcumin on expression of VEGF in polycystic ovary syndrome rat models by  WANG Lian-lian, LI Cong, MENG Jiang-ping, YANG Xi (Journal of Shanghai, Jiaotong Uncersity)   

(626) Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study by Mehrabani HH, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F.(PubMed)

(626a) The beneficial effects of High Protein Diet with Low-Glycemic-Load Hypocaloric Diet in overweight and obese women with PCOs: a ramdomized control conventional study(Research online, University of Wollongong)

(627) Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome by Esfahanian F, Zamani MM, Heshmat R, Moini nia F.(PubMed)

(628) Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations by Heggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S.(PubMed)

(629) The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary eby Thomson RL, Brinkworth GD, Noakes M, Clifton PM, Norman RJ, Buckley JD.(PubMed)

(630) Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study by Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.(PubMed)

(631) Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial by Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, Zullo F, Orio F.(PubMed)

(632) Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome by Ornstein RM, Copperman NM, Jacobson MS.(PubMed)

(633) A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome by Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS.(PubMed)

(634) Toxicity of hypercaloric diet and monosodium glutamate: oxidative stress and metabolic shifting in hepatic tissue by Diniz YS, Fernandes AA, Campos KE, Mani F, Ribas BO, Novelli EL.(PubMed)

(635) The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study by Mavropoulos JC, Yancy WS, Hepburn J, Westman EC.(PubMed)

(636) Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets by Paoli A, Rubini A, Volek JS, Grimaldi KA.(PubMed)

(637) Eades, M. (1995) The Protein Power Lifeplan, Warner Books.

(638) Early- and Late-onset Complications of the Ketogenic Diet for Intractable Epilepsy by Hoon Chul Kang¹, Da Eun Chung¹, Dong Wook Kim², Heung Dong Kim (Wily online library)

(639) An isocaloric low glycemic index diet improves insulin sensitivity in women with polycystic ovary syndrome by Barr S, Reeves S, Sharp K, Jeanes YM.(PubMed)

(640) Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome by Marsh KA, Steinbeck KS, Atkinson FS, Petocz P, Brand-Miller JC.(PubMed)

(641) The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus by Eric C Westman^1*, William S Yancy¹², John C Mavropoulos¹, Megan Marquart¹ and Jennifer R McDuffie(Nutrition&Metabolism)

(642) Evaluating compliance to a low glycaemic index (GI) diet in women with polycystic ovary syndrome (PCOS) by Egan N, Read A, Riley P, Atiomo W.(PubMed)

(643) Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study by Toscani MK, Mario FM, Radavelli-Bagatini S, Wiltgen D, Matos MC, Spritzer PM.(PubMed)

(644) Carbohydrate-restricted diets high in either monounsaturated fat or protein are equally effective at promoting fat loss and improving blood lipids by Luscombe-Marsh ND, Noakes M, Wittert GA, Keogh JB, Foster P, Clifton PM.(PubMed)

(645) Effects of high-whey-protein intake and resistance training on renal, bone and metabolic parameters in rats by Aparicio VA, Nebot E, Porres JM, Ortega FB, Heredia JM, López-Jurado M, Ramírez PA.(PubMed)

(646) Effects of dietary protein and glycaemic index on biomarkers of bone turnover in children by Dalskov SM¹, Müller M², Ritz C¹, Damsgaard CT¹, Papadaki A³, Saris WH⁴, Astrup A¹, Michaelsen KF¹, Mølgaard C¹; on behalf of DiOGenes(PubMed)

(647) Carbohydrate-restricted diets high in either monounsaturated fat or protein are equally effective at promoting fat loss and improving blood lipids by Luscombe-Marsh ND, Noakes M, Wittert GA, Keogh JB, Foster P, Clifton PM.(PubMed)

(648) Obesity and the Mediterranean diet: a systematic review of observational and intervention studies by Buckland G, Bach A, Serra-Majem L.(PubMed)

(649) Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome by Katcher HI, Kunselman AR, Dmitrovic R, Demers LM, Gnatuk CL, Kris-Etherton PM, Legro RS.(PubMed)

(650) Effects of a low-fat vegan diet and a Step II diet on macro- and micronutrient intakes in overweight postmenopausal women by Turner-McGrievy GM, Barnard ND, Scialli AR, Lanou AJ.(PubMed)

(651) Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines by Moran LJ, Ko H, Misso M, Marsh K, Noakes M, Talbot M, Frearson M, Thondan M, Stepto N, Teede HJ.(PubMed)

(652) A 24-week, prospective, randomized, open-label, treat-to-target pilot study of obese type 2 diabetes patients with severe insulin resistance to assess the addition of exenatide on the efficacy of u-500 regular insulin plus metformin by Distiller LA¹, Nortje H², Wellmann H³, Amod A⁴, Lombard L⁵.(PubMed)

(653) One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target by Rosenstock J¹, Rodbard HW, Bain SC, D'Alessio D, Seufert J, Thomsen AB, Svendsen CB, DeVries JH; Liraglutide-Detemir Study Group.(PubMed)

(654) An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials by Sun J¹, Yuan Y¹, Cai R¹, Sun H¹, Zhou Y¹, Wang P¹, Huang R¹, Xia W¹, Wang S¹.(PubMed)

(655) Polycystic ovary syndrome (PCOS): metformin by Cahill DJ¹, O'Brien K.(PubMed)

(656) Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome by Kazerooni T¹, Dehghan-Kooshkghazi M.(PubMed)

(657) Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes by Lee A¹, Morley JE.(PubMed)

(658) The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes by Freemark M¹, Bursey D.(PubMed)

(659) Reducing insulin resistance with metformin: the evidence today by Giannarelli R¹, Aragona M, Coppelli A, Del Prato S.(PubMed)

(660) Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus by Fournier JP¹, Yin H¹, Yu OH¹, Azoulay L².(PubMed)

(661) Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats by Duca FA¹, Côté CD², Rasmussen BA², Zadeh-Tahmasebi M², Rutter GA³, Filippi BM¹, Lam TK⁴.(PubMed)

(662) Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study by Uysal S¹, Zeki Isik A², Eris S³, Yigit S⁴, Yalcin Y⁵, Ozun Ozbay P⁶.(PubMed)

(663) Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial by Morin-Papunen L¹, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Bloigu R, Puukka K, Ruokonen A, Tapanainen JS.(PubMed)

(664) Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model by Di Pietro M¹, Parborell F, Irusta G, Pascuali N, Bas D, Bianchi MS, Tesone M, Abramovich D.(PubMed)

(665) Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients by Tarasova L¹, Kalnina I, Geldnere K, Bumbure A, Ritenberga R, Nikitina-Zake L, Fridmanis D, Vaivade I, Pirags V, Klovins J.(PubMed)

(666) Ondansetron and metformin-induced gastrointestinal side effects by Hoffmann IS¹, Roa M, Torrico F, Cubeddu LX.(PubMed)

(667) Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome by Tso LO¹, Costello MF, Albuquerque LE, Andriolo RB, Macedo CR.(PubMed)

(668) Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects by Fisman EZ¹, Motro M, Tenenbaum A.(PubMed)

(669) Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial by Ji L¹, Zinman B, Patel S, Ji J, Bailes Z, Thiemann S, Seck T.(PubMed)

(670) Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers by Perri T¹, Lifshitz D², Sadetzki S³, Oberman B⁴, Meirow D⁵, Ben-Baruch G², Friedman E⁶, Korach J².(PubMed)

(671) Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications by Sivalingam VN¹, Myers J², Nicholas S³, Balen AH³, Crosbie EJ⁴.(PubMed)

(672) The association between follicular size at the time of spontaneous rupture and pregnancy rates in clomiphene citrate treated PCOS patients in coit cycles by Portocarrero-Sanchez C¹, Gomes-Sobrinho DB, Nakagawa HM, Silva AA, Carvalho BR, Sarkis NT, Peraçoli JC, Cardoso MT.(PubMed)

(673) Clomid- Clomiphene Citrat(The reproductive medincine and surgery center of |Virginia. PLC)

(674) Metformin combined with clomiphene citrate may increase ovulation rates and pregnancy rates but does not significantly improve the live birth rate over that of clomiphene citrate alone.(I-A) Ovulation induction in polycystic ovary syndrome by Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin JA, Lapensée L, Stewart S, Wong BC; Society of Obstetricians and Gynecologists of Canada.(PubMed)

(675) [Infertility in polycystic ovary syndrome treated with acupuncture and clomiphene: a randomized controlled trial].[Article in Chinese]by Jiang D, Zhang Y, Wu X, Wu S.(PubMed)

(676) Clomiphene therapy in epileptic women with menstrual disorders by Herzog AG1(PubMed)

(677) Massive ovarian edema in pregnancy after ovulation induction using clomiphene citrate by Kawaguchi R¹, Ueda S, Tsuji Y, Haruta S, Kanayama S, Yamada Y, Ooi H, Kobayashi H.(PubMed)

(678) Massive ovarian edema in a woman receiving clomiphene citrate. A case report by Patty JR¹, Galle PC, McRae MA.(PubMed)

(679) Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs by Althuis MD¹, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA.(PubMed)

(680) Psychological side-effects of clomiphene citrate and human menopausal gonadotrophin by Choi SH¹, Shapiro H, Robinson GE, Irvine J, Neuman J, Rosen B, Murphy J, Stewart D.(PubMed)

(681) Letrozole versus clomiphene for infertility in the polycystic ovary syndrome by Legro RS¹, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H; NICHD Reproductive Medicine Network.(PubMed)

(682) Clomiphene citrate as a possible cause of a psychotic reaction during infertility treatment by Siedentopf F¹, Horstkamp B, Stief G, Kentenich H.(PubMed)

(683) [Efficacy and safety evaluation of acupuncture combined with auricular point sticking therapy in the treatment of polycystic ovary syndrome].[Article in Chinese]by Li N¹.(PubMed)

(684) Fertility drugs, reproductive strategies and ovarian cancer risk by Tomao F¹, Lo Russo G², Spinelli GP², Stati V², Prete AA², Prinzi N³, Sinjari M², Vici P⁴, Papa A², Chiotti MS², Benedetti Panici P¹, Tomao S².(PubMed)

(685) Ovarian cancer risk after the use of ovulation-stimulating drugs by Brinton LA¹, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL.(PubMed)

(686) New discoveries on the biology and detection of human chorionic gonadotropin by Laurence A Cole(PubMed)

(687) α-Fetoprotein and β-Human Chorionic Gonadotropin by John J. Gregory Jr, and Dr Jonathan L. Finlay(Spingerlink)

(688) human chorionic gonadotropin (HCG)(Drug.com)

(689) Ectopic pregnancy after in-vitro fertilization is characterized by delayed implantation but a normal increase of serum human chorionic gonadotrophin and its subunits by Korhonen J¹, Tiitinen A, Alfthan H, Ylöstalo P, Stenman UH.(PubMed)

(690) Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination by Mitwally MF¹, Abdel-Razeq S, Casper RF.(PubMed)

(691) A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS by Ramezanzadeh F¹, Nasiri R, Sarafraz Yazdi M, Baghrei M.(PubMed)

(692) Changes in chronic low back pain and cardiovascular risk factors using a homeopathic human chorionic gonadotropin-based weight loss program: a case report by Morningstar MW¹, Strauchman MN.(PubMed)

(693) An unfortunate resurgence of human chorionic gonadotropin use for weight loss by Lovejoy JC¹, Sasagawa M.(PubMed)

(694) Human chorionic gonadotropin is of no value in the management of obesity by C. L. Birmingham and K. C. Smith(PubMed)

(695) Ocular adverse effects of human chorionic gonadotropin by Lee M, Fried WI, Sharifi R.(PubMed)

(696) Synchronised approach for intrauterine insemination in subfertile couples by Cantineau AE¹, Janssen MJ, Cohlen BJ, Allersma T.(PubMed)

(697) HcG(Drug.com)

(698) Pregnancy outcomes after assisted reproductive technology.[Article in English, French] by Allen VM¹, Wilson RD, Cheung A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC); Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC).(PubMed)

(699) Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities by van de Weijer BH¹, Mulders JW, Bos ES, Verhaert PD, van den Hooven HW.(PubMed)

1. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part I) - The Prevention
2. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies (Part II)- The Conventional Supplement page
3. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part III) - The Weight loss approach

4. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part IV) - The Herbal Medicine approach

5. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(Part V) - The TCM approach

6. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(references page of 1 - 699)

7. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(References page of 700 -1499)

8. The Holistic Prevention, Management of PCOs analysed through Conventional Medicine Research and Studies(References page 1500-2333)

Back to Home page